[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_byId_6f1e247e-07ab-47c0-8121-210887c600a9":3,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:6f1e247e-07ab-47c0-8121-210887c600a9,\"}":91},{"code":4,"data":5,"meta":18},"SUCCESS",{"id":6,"createTime":7,"updateTime":8,"relativeEntities":9,"slug":10,"properties":11,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":20,"manageAffiliations":29,"indexDatabases":52,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},"6f1e247e-07ab-47c0-8121-210887c600a9","2023-12-05T06:02:52.412+00:00","2025-11-21T09:47:54.776+00:00",[],"Journal-of-Drug-Delivery-Science-and-Technology",{"issn":12,"title":14},{"VOID":13},"17732247",{"EN":15},"Journal of Drug Delivery Science and Technology","PUBLISHER","PENDING",null,0,[21],{"id":22,"createTime":23,"updateTime":24,"relativeEntities":25,"label":26,"description":28,"parentId":18,"standard":18,"scholarHubFieldId":18},"988aad6e-c496-4836-b969-f61991a0eed2","2023-05-29T10:24:08.494+00:00","2023-11-21T05:14:42.646+00:00",[],{"EN":27},"Pharmaceutical Science",{},[30,42],{"id":31,"createTime":32,"updateTime":33,"relativeEntities":34,"slug":35,"properties":36,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":40,"url":18,"parentIds":41,"statistic":18},"5250c8e7-ad5b-4a6c-9f8b-4a3b7026f039","2023-05-29T11:13:21.321+00:00","2025-11-21T10:01:41.480+00:00",[],"Editions-de-Sante",{"title":37},{"EN":38},"Editions de Sante","AFFILIATION",5,[],{"id":43,"createTime":44,"updateTime":45,"relativeEntities":46,"slug":47,"properties":48,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":50,"url":18,"parentIds":51,"statistic":18},"c749757b-dddf-4e6f-9697-b9c441adc06c","2023-05-29T10:24:07.401+00:00","2025-11-21T10:06:14.206+00:00",[],"Elsevier",{"title":49},{"EN":47},11,[],[53,72],{"id":54,"indexDatabase":55,"url":69,"indexYears":18,"academicFieldIds":70,"indexDatabaseRanking":18},"f9fa6426-a8d7-4956-98cc-db36ce3b5d7f",{"id":56,"createTime":57,"updateTime":58,"relativeEntities":59,"label":60,"description":62,"key":65,"publicationTags":66,"standard":18},"a4921856-b128-4d9f-8f1f-e80813d3bbd4","2023-05-22T09:59:31.026+00:00","2025-11-21T10:07:52.153+00:00",[],{"EN":61,"VI":61},"ISI\u002FSCIE - Science Citation Index Expanded",{"VI":63,"EN":64},"Cơ sở dữ liệu SCIE","SCIE database","scie",[67,68],"SCIE","ISI","https:\u002F\u002Fmjl.clarivate.com\u002Fsearch-results?issn=1773-2247",[71],"2b943d65-24a8-4546-9232-a1e32c12cb6c",{"id":73,"indexDatabase":74,"url":86,"indexYears":87,"academicFieldIds":88,"indexDatabaseRanking":90},"61e68648-0c2c-4ae5-ba2e-4b0808c7303c",{"id":75,"createTime":76,"updateTime":77,"relativeEntities":78,"label":79,"description":81,"key":83,"publicationTags":84,"standard":18},"3c7051d4-eb7d-4c57-a56b-36fc74c5d1e9","2023-05-22T09:57:18.509+00:00","2025-11-21T10:07:52.274+00:00",[],{"EN":80,"VI":80},"Scopus - Elsevier",{"EN":80,"VI":82},"Cơ sở dữ liệu Scopus thuộc Elsevier","scopus",[85],"SCOPUS","https:\u002F\u002Fwww.scopus.com\u002Fsourceid\u002F22204","2004-2025",[89],"6e740848-171b-4f21-8d03-9fed10ed0384","SCOPUS__Q2",{"meta":92,"data":94},{"total":93},"2610",[95,197,325,409,549,679,786,949,1021,1135],{"id":96,"createTime":97,"updateTime":98,"relativeEntities":99,"slug":100,"properties":101,"entityType":108,"verifyStatus":109,"verifyTime":98,"verifyNote":110,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":111,"fullTextUrl":18,"authors":112,"publicationType":165,"publisherRelationship":166,"citationCount":18,"citationInfo":18,"publishDate":194,"publishYear":195,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":196},"41697797-3581-4c1b-a057-c51def9b801b","2023-12-29T00:23:06.178+00:00","2025-01-22T23:59:42.991+00:00",[],"Optimization-and-in-vitro-evaluation-of-ziprasidone-nanosuspensions-produced-by-a-top-down-approach",{"references":102,"title":104,"doi":106},{"VOID":103},"Müller, 2011, State of the art of nanocrystals - special features, production, nanotoxicology aspects and intracellular delivery, Eur. J. Pharm. Biopharm., 78, 1, 10.1016\u002Fj.ejpb.2011.01.007\nGao, 2012, Drug nanocrystals: in vivo performances, J. Control. Release, 160, 418, 10.1016\u002Fj.jconrel.2012.03.013\nAhuja, 2015, Formulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspension, Int. J. Pharm., 478, 540, 10.1016\u002Fj.ijpharm.2014.12.003\nMüller, 2001, Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future, Adv. Drug Deliv. Rev., 47, 3, 10.1016\u002FS0169-409X(00)00118-6\nDolenc, 2009, Advantages of celecoxib nanosuspension formulation and transformation into tablets, Int. J. Pharm., 376, 204, 10.1016\u002Fj.ijpharm.2009.04.038\nQuan, 2012, A novel surface modified nitrendipine nanocrystals with enhancement of bioavailability and stability, Int. J. Pharm., 430, 366, 10.1016\u002Fj.ijpharm.2012.04.025\nChan, 2011, Production methods for nanodrug particles using the bottom-up approach, Adv. Drug Deliv. Rev., 63, 406, 10.1016\u002Fj.addr.2011.03.011\nKeck, 2006, Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation, Eur. J. Pharm. Biopharm., 62, 3, 10.1016\u002Fj.ejpb.2005.05.009\nKarakucuk, 2016, Preparation of ritonavir nanosuspensions by microfluidization using polymeric stabilizers: I. A Design of Experiment approach, Eur. J. Pharm. Sci., 95, 111, 10.1016\u002Fj.ejps.2016.05.010\nBobes, 2004, Economic consequences of the adverse reactions related with antipsychotics: an economic model comparing tolerability of ziprasidone, olanzapine, risperidone, and haloperidol in Spain, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 28, 1287, 10.1016\u002Fj.pnpbp.2004.06.017\nBrinholi, 2016, Clozapine and olanzapine are better antioxidants than haloperidol, Quetiapine, Risperidone and ziprasidone in in vitro models, Biomed. Pharmacother., 81, 411, 10.1016\u002Fj.biopha.2016.02.047\nCoplan, 2013, Tardive dyskinesia from atypical antipsychotic agents in patients with mood disorders in a clinical setting, J. Affect. Disord., 150, 868, 10.1016\u002Fj.jad.2013.04.053\nThombre, 2015, Pharmacoscintigraphy studies to assess the feasibility of a controlled release formulation of ziprasidone, J. Control. Release, 213, 10, 10.1016\u002Fj.jconrel.2015.06.032\nTeeranachaideekul, 2008, Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology, Int. J. Pharm., 354, 227, 10.1016\u002Fj.ijpharm.2007.11.062\nGuo, 2013, Development and in vivo\u002Fin vitro evaluation of novel herpetrione nanosuspension, Int. J. Pharm., 441, 227, 10.1016\u002Fj.ijpharm.2012.11.039\nVerma, 2011, Physical stability of nanosuspensions: investigation of the role of stabilizers on Ostwald ripening, Int. J. Pharm., 406, 145, 10.1016\u002Fj.ijpharm.2010.12.027\nGeorge, 2013, Identifying the correlation between drug\u002Fstabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology, Eur. J. Pharm. Sci., 48, 142, 10.1016\u002Fj.ejps.2012.10.004\nOktay, 2018, Dermal flurbiprofen nanosuspensions: optimization with design of experiment approach and in vitro evaluation, Eur. J. Pharm. Sci., 10.1016\u002Fj.ejps.2018.07.009\nTuomela, 2016, Production, applications and in vivo fate of drug nanocrystals, J. Drug Deliv. Sci. Technol., 34, 21, 10.1016\u002Fj.jddst.2016.02.006\nDewalkar, 2012\nBera, 2015, Mucoadhesive-floating zinc-pectinate-sterculia gum interpenetrating polymer network beads encapsulating ziprasidone HCl, Carbohydr. Polym., 131, 108, 10.1016\u002Fj.carbpol.2015.05.042\nWang, 2013, Stability of nanosuspensions in drug delivery, J. Control. Release, 172, 1126, 10.1016\u002Fj.jconrel.2013.08.006\nHong, 2014, Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation, Int. J. Pharm., 477, 251, 10.1016\u002Fj.ijpharm.2014.10.044\nChaubal, 2008, Conversion of nanosuspensions into dry powders by spray drying: a case study, Pharm. Res. (N. Y.), 25, 2302, 10.1007\u002Fs11095-008-9625-0\nDressman, 2000, In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs, Eur. J. Pharm. Sci., 10.1016\u002FS0928-0987(00)00181-0\nMiceli, 2007, The effect of food on the absorption of oral ziprasidone, Psychopharmacol. Bull., 40, 58\nThombre, 2012, In vitro and in vivo characterization of amorphous, nanocrystalline, and crystalline ziprasidone formulations, Int. J. Pharm., 428, 8, 10.1016\u002Fj.ijpharm.2012.02.004\nKlein, 2010, The use of biorelevant dissolution media to forecast the in vivo performance of a drug, AAPS J., 12, 397, 10.1208\u002Fs12248-010-9203-3\nSinha, 2013, Bottom-up approaches for preparing drug nanocrystals: formulations and factors affecting particle size, Int. J. Pharm., 453, 126, 10.1016\u002Fj.ijpharm.2013.01.019\nZhang, 2010, DDSolver: an add-in program for modeling and comparison of drug dissolution profiles, AAPS J., 12, 263, 10.1208\u002Fs12248-010-9185-1\nDening, 2016, Silica encapsulated lipid-based drug delivery systems for reducing the fed\u002Ffasted variations of ziprasidone in vitro, Eur. J. Pharm. Biopharm., 101, 33, 10.1016\u002Fj.ejpb.2016.01.010",{"EN":105},"Optimization and in vitro evaluation of ziprasidone nanosuspensions produced by a top-down approach",{"VOID":107},"10.1016\u002Fj.jddst.2019.04.024","PUBLICATION","VERIFIED","Auto Verify","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1773224719300395",[113,130,152],{"id":114,"sortIndex":115,"researcher":18,"roles":116,"affiliations":118,"properties":127},"8218c848-705d-47cf-9aa4-80816aab9dba",1,[117],"AUTHOR",[119],{"id":18,"sortIndex":19,"affiliation":120,"properties":18},{"id":121,"createTime":122,"updateTime":122,"relativeEntities":123,"slug":18,"properties":124,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"5fe6a4ab-eedc-4c5d-b364-94dbd93d4f47","2023-12-06T06:41:02.028+00:00",[],{"title":125},{"VI":126},"Department of Pharmaceutical Technology, Faculty of Pharmacy, Gazi University, Ankara, Turkey",{"title":128},{"VI":129},"Alptug Karakucuk",{"id":131,"sortIndex":19,"researcher":18,"roles":132,"affiliations":133,"properties":149},"b160232b-4183-424f-a735-d5d4fdb41a1a",[117],[134,144],{"id":135,"sortIndex":115,"affiliation":136,"properties":143},"8ae7d96d-8d53-4ad1-a350-68a46093d8a8",{"id":137,"createTime":138,"updateTime":138,"relativeEntities":139,"slug":18,"properties":140,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"8e14e258-c101-4594-91fb-006b94637454","2024-01-25T02:17:16.648+00:00",[],{"title":141},{"VI":142},"Zoleant Pharmaceuticals International, Istanbul, Turkey",{},{"id":18,"sortIndex":19,"affiliation":145,"properties":18},{"id":121,"createTime":122,"updateTime":122,"relativeEntities":146,"slug":18,"properties":147,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":148},{"VI":126},{"title":150},{"VI":151},"Emine Tashan",{"id":153,"sortIndex":154,"researcher":18,"roles":155,"affiliations":156,"properties":162},"fc5788c2-b3d8-44bd-a062-9ed6a8f145ef",2,[117],[157],{"id":18,"sortIndex":19,"affiliation":158,"properties":18},{"id":121,"createTime":122,"updateTime":122,"relativeEntities":159,"slug":18,"properties":160,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":161},{"VI":126},{"title":163},{"VI":164},"Nevin Celebi","ARTICLE",{"url":111,"publisher":167,"properties":189},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":168,"slug":10,"properties":169,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":172,"manageAffiliations":173,"indexDatabases":174,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":170,"title":171},{"VOID":13},{"EN":15},[],[],[175,182],{"id":73,"indexDatabase":176,"url":86,"indexYears":87,"academicFieldIds":181,"indexDatabaseRanking":90},{"id":75,"createTime":76,"updateTime":77,"relativeEntities":177,"label":178,"description":179,"key":83,"publicationTags":180,"standard":18},[],{"EN":80,"VI":80},{"EN":80,"VI":82},[85],[89],{"id":54,"indexDatabase":183,"url":69,"indexYears":18,"academicFieldIds":188,"indexDatabaseRanking":18},{"id":56,"createTime":57,"updateTime":58,"relativeEntities":184,"label":185,"description":186,"key":65,"publicationTags":187,"standard":18},[],{"EN":61,"VI":61},{"VI":63,"EN":64},[67,68],[71],{"volume":190,"pages":192},{"VOID":191},"52",{"VOID":193},"37-45","2019-08-01",2019,false,{"id":198,"createTime":199,"updateTime":200,"relativeEntities":201,"slug":202,"properties":203,"entityType":108,"verifyStatus":109,"verifyTime":200,"verifyNote":110,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":210,"fullTextUrl":18,"authors":211,"publicationType":165,"publisherRelationship":295,"citationCount":18,"citationInfo":18,"publishDate":323,"publishYear":324,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":196},"e2f4ce3e-4c31-463b-a5b6-2726ef4e9ccd","2024-01-21T22:02:21.822+00:00","2025-01-31T23:59:11.325+00:00",[],"Is-Combihaler-usable-for-aerosol-delivery-in-single-limb-non-invasive-mechanical-ventilation-",{"references":204,"title":206,"doi":208},{"VOID":205},"Michotte, 2014, In vitro comparison of five nebulizers during noninvasive ventilation: analysis of inhaled and lost doses, J. Aerosol Med. Pulm. Drug Deliv., 27, 430, 10.1089\u002Fjamp.2013.1070\nDuarte, 2004, Inhaled bronchodilator administration during mechanical ventilation, Respir. Care, 49, 623\nBerlinski, 2013, Albuterol delivery by 4 different nebulizers placed in 4 different positions in a pediatric ventilator in vitro model, Respir. Care, 58, 1124, 10.4187\u002Frespcare.02074\nSidler-Moix, 2015, Physicochemical aspects and efficiency of albuterol nebulization: comparison of three aerosol types in an in vitro pediatric model, Respir. Care, 60, 38, 10.4187\u002Frespcare.02490\nGhazanfari, 2007, The influence of fluid physicochemical properties on vibrating-mesh nebulization, Int. J. Pharm., 339, 103, 10.1016\u002Fj.ijpharm.2007.02.035\nHassan, 2016, In-vitro characterization of the aerosolized dose during non-invasive automatic continuous positive airway pressure ventilation, Pulm. Ther., 2, 115, 10.1007\u002Fs41030-015-0010-y\nElHansy, 2016, In vitro aerodynamic characteristics of aerosol delivered from different inhalation methods in mechanical ventilation, Pharm. Dev. Technol., 1\nDhand, 1997, Inhaled bronchodilator therapy in mechanically ventilated patients, Am. J. Respir. Crit. Care Med., 156, 3, 10.1164\u002Fajrccm.156.1.9610025\nDhand, 2004, New frontiers in aerosol delivery during mechanical ventilation, Respir. Care, 49, 667\nAri, 2010, Influence of nebulizer type, position, and bias flow on aerosol drug delivery in simulated pediatric and adult lung models during mechanical ventilation, Respir. Care, 55, 845\nWaldrep, 2008, Advanced nebulizer designs employing vibrating mesh\u002Faperture plate technologies for aerosol generation, Curr. Drug Deliv., 5, 114, 10.2174\u002F156720108783954815\nDhand, 2002, Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol, Respir. Care, 47, 1406\nDhand, 2003, New nebuliser technology-aerosol generation by using a vibrating mesh or plate with multiple apertures, Bus. Brief. long-therm health care Strateg., 1\nWatts, 2008, Current therapies and technological advances in aqueous aerosol drug delivery, Drug Dev. Ind. Pharm., 34, 913, 10.1080\u002F03639040802144211\nAbdelrahim, 2010, In-vitro characterisation of the nebulised dose during non-invasive ventilation, J. Pharm. Pharmacol., 62, 966, 10.1111\u002Fj.2042-7158.2010.01134.x\nFink, 2001, Aerosol delivery during mechanical ventilation with high frequency oscillation: an in-vitro evaluation, Chest, 120, 277S\nFink, 2003, In vitro comparison of a novel nebulizer with ultrasonic and pneumatic nebulizers, J. Allergy Clin. Immunol. Pract., 111, S143, 10.1016\u002FS0091-6749(03)80454-2\nChrystyn, 2004, Relative bioavailability of salbutamol to the lungs following inhalation by three nebulised methods, Abstr. Am. Thorac. Soc. Meet.\nBoukhettala, 2015, In vitro performance of spacers for aerosol delivery during adult mechanical ventilation, J. Aerosol Med. Pulm. Drug Deliv., 28, 130, 10.1089\u002Fjamp.2013.1091\nAri, 2015, Performance comparisons of jet and mesh nebulizers using different interfaces in simulated spontaneously breathing adults and children, J. Aerosol Med. Pulm. Drug Deliv., 28, 281, 10.1089\u002Fjamp.2014.1149\nHarvey, 1995, Effect of a spacer on pulmonary aerosol deposition from a jet nebuliser during mechanical ventilation, Thorax, 50, 50, 10.1136\u002Fthx.50.1.50\nLabiris, 2003, Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications, Br. J. Clin. Pharmacol., 56, 588, 10.1046\u002Fj.1365-2125.2003.01892.x\nLourenço, 1972, Patterns of distribution and clearance of aerosols in patients with bronchiectasis 1, 2, Am. Rev. Respir. Dis., 106, 857, 10.1164\u002Farrd.1972.106.6.857\nLaube, 1986, The effect of bronchial obstruction on central airway deposition of a saline aerosol in patients with asthma, Am. Rev. Respir. Dis., 133, 740\nPavia, 1977, Effect of lung function and mode of inhalation on penetration of aerosol into the human lung, Thorax, 32, 194, 10.1136\u002Fthx.32.2.194\nIlowite, 1987, Quantitative deposition of aerosolized gentamicin in cystic Fibrosis1-3, Am. Rev. Respir. Dis., 136, 1445, 10.1164\u002Fajrccm\u002F136.6.1445\nBoukhettala, 2012, In vitro evaluation of a new spacer for pMDI and nebulizers in mechanical ventilation, Eur. Respir. J., 40, P2012\nBoukhettala, 2013, Study of the performances of a new spacer in adult mechanical ventilation, Eur. Respir. J., 42, P3861\nAbdelrahim, 2011, The relative lung and systemic bioavailability of terbutaline following nebulisation in non-invasively ventilated patients, Int. J. Pharm., 420, 313, 10.1016\u002Fj.ijpharm.2011.09.005\nHassan, 2017, In-vitro\u002Fin-vivo comparison of inhaled salbutamol dose delivered by jet nebulizer, vibrating mesh nebulizer and metered dose inhaler with spacer during non-invasive ventilation, Exp. Lung Res., 43, 19, 10.1080\u002F01902148.2017.1282993\nHussein, 2017, In vitro\u002Fin vivo correlation and modeling of emitted dose and lung deposition of inhaled salbutamol from metered dose inhalers with different types of spacers in noninvasively ventilated patients, Pharm. Dev. Technol., 1\nRabea, 2017, Modelling of in-vitro and in-vivo performance of aerosol emitted from different vibrating mesh nebulisers in non-invasive ventilation circuit, Eur. J. Pharm. Sci., 97, 182, 10.1016\u002Fj.ejps.2016.11.018\nMadney, 2017, Nebulizers and spacers for aerosol delivery through adult nasal cannula at low oxygen flow rate: an in-vitro study, J. Drug Deliv. Sci. Technol., 39, 260, 10.1016\u002Fj.jddst.2017.04.014\nAri, 2015, Pressurized metered-dose inhalers versus nebulizers in the treatment of mechanically ventilated subjects with artificial airways: an in vitro study, Respir. Care, 60, 1570, 10.4187\u002Frespcare.04125\nBerlinski, 2013, Albuterol delivery via metered dose inhaler in a spontaneously breathing pediatric tracheostomy model, Pediatr. Pulmonol., 48, 1026, 10.1002\u002Fppul.22715\nBerg, 2007, Determination of nebulizer droplet size distribution: a method based on impactor refrigeration, J. Aerosol Med., 20, 97, 10.1089\u002Fjam.2007.0556\nAbdelrahim, 2009, Aerodynamic characteristics of nebulized terbutaline sulphate using the next generation impactor (NGI) and CEN method, J. Aerosol Med. Pulm. Drug Deliv., 22, 19, 10.1089\u002Fjamp.2008.0650\n2011, Aerodynamic characteristics of nebulized terbutaline sulphate using the Andersen Cascade Impactor compared to the next generation impactor, Pharm. Dev. Technol., 16, 137, 10.3109\u002F10837450903511194\nDai, 2014, Influence of exhalation valve and nebulizer position on albuterol delivery during noninvasive positive pressure ventilation, J. Aerosol Med. Pulm. Drug Deliv., 27, 125, 10.1089\u002Fjamp.2012.1024\nCalvert, 2006, Enhanced delivery of nebulised salbutamol during non-invasive ventilation, J. Pharm. Pharmacol., 58, 1553, 10.1211\u002Fjpp.58.11.0017\nMorén, 1978, Drug deposition of pressurized inhalation aerosols I. Influence of actuator tube design, Int. J. Pharm., 1, 205, 10.1016\u002F0378-5173(78)90009-1\nWilliams, 1998, Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler, Drug Dev. Ind. Pharm., 24, 763, 10.3109\u002F03639049809082724\nDhand, 2004, Basic techniques for aerosol delivery during mechanical ventilation, Respir. Care, 49, 611\nBarry, 1995, The optimum size and shape of spacer devices for inhalational therapy, J. Aerosol Med., 8, 303, 10.1089\u002Fjam.1995.8.303\nNikander, 2014, The evolution of spacers and valved holding chambers, J. Aerosol Med. Pulm. Drug Deliv., 27, S-4, 10.1089\u002Fjamp.2013.1076\nDoyle, 2009\nBoukhettala, 2015, In vitro evaluation of a spacer in a pediatric model of mechanical ventilation, Eur. Respir. J., 46, PA1868\nZanen, 1996, Optimal particle size for beta 2 agonist and anticholinergic aerosols in patients with severe airflow obstruction, Thorax, 51, 977, 10.1136\u002Fthx.51.10.977\nUsmani, 2005, Regional lung deposition and bronchodilator response as a function of β2-agonist particle size, Am. J. Respir. Crit. care Med., 172, 1497, 10.1164\u002Frccm.200410-1414OC\nNewman, 2005, Principles of metered-dose inhaler design, Respir. Care, 50, 1177\nWildhaber, 2000, Reducing electrostatic charge on spacer devices and bronchodilator response, Br. J. Clin. Pharmacol., 50, 277, 10.1046\u002Fj.1365-2125.2000.00251.x\nKenyon, 1998, The effects of static charge in spacer devices on glucocorticosteroid aerosol deposition in asthmatic patients, Eur. Respir. J., 11, 606, 10.1183\u002F09031936.98.11030606\nBarry, 1995, The effect of delay, multiple actuations and spacer static charge on the in vitro delivery of budesonide from the Nebuhaler, Br. J. Clin. Pharmacol., 40, 76, 10.1111\u002Fj.1365-2125.1995.tb04538.x\nLi, 1992, Dispersion and deposition of spherical particles from point sources in a turbulent channel flow, Aerosol Sci. Technol., 16, 209, 10.1080\u002F02786829208959550",{"EN":207},"Is Combihaler usable for aerosol delivery in single limb non-invasive mechanical ventilation?",{"VOID":209},"10.1016\u002Fj.jddst.2017.05.022","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1773224717302939",[212,228,243,268,280],{"id":213,"sortIndex":214,"researcher":18,"roles":215,"affiliations":216,"properties":225},"6d5f0766-a3f2-4f63-bc4e-231d24106219",3,[117],[217],{"id":18,"sortIndex":19,"affiliation":218,"properties":18},{"id":219,"createTime":220,"updateTime":220,"relativeEntities":221,"slug":18,"properties":222,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"85769a88-a5b5-4a6c-bc3f-bf9901ea3402","2024-01-21T22:02:21.925+00:00",[],{"title":223},{"VI":224},"Respiratory Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt",{"title":226},{"VI":227},"Maha Fathy",{"id":229,"sortIndex":154,"researcher":18,"roles":230,"affiliations":231,"properties":240},"e12f9f27-8836-4be2-a0e2-b3b0aece9513",[117],[232],{"id":18,"sortIndex":19,"affiliation":233,"properties":18},{"id":234,"createTime":235,"updateTime":235,"relativeEntities":236,"slug":18,"properties":237,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"85f051f8-1c9d-4f94-a588-3d0f3d46af4e","2024-01-11T09:17:05.560+00:00",[],{"title":238},{"VI":239},"Clinical Pharmacy Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt",{"title":241},{"VI":242},"Hoda Rabea",{"id":244,"sortIndex":245,"researcher":18,"roles":246,"affiliations":247,"properties":265},"0e7b1d56-41e7-419f-a30d-31db29f25379",4,[117],[248,260],{"id":249,"sortIndex":115,"affiliation":250,"properties":259},"d975c398-8398-4456-9d04-d2a257c0c1a3",{"id":251,"createTime":252,"updateTime":253,"relativeEntities":254,"slug":255,"properties":256,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"06b0a1a8-154b-440c-8120-1f912f793a57","2024-01-14T18:44:28.459+00:00","2025-06-11T19:45:03.013+00:00",[],"Clinical-Pharmacy-Department-Faculty-of-Pharmacy-Ahram-Canadian-University-Giza-Egypt",{"title":257},{"VI":258},"Clinical Pharmacy Department, Faculty of Pharmacy, Ahram Canadian University, Giza, Egypt",{},{"id":18,"sortIndex":19,"affiliation":261,"properties":18},{"id":234,"createTime":235,"updateTime":235,"relativeEntities":262,"slug":18,"properties":263,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":264},{"VI":239},{"title":266},{"VI":267},"Mohamed E.A. Abdelrahim",{"id":269,"sortIndex":19,"researcher":18,"roles":270,"affiliations":271,"properties":277},"e8b7809b-2895-464f-8668-02278df4521b",[117],[272],{"id":18,"sortIndex":19,"affiliation":273,"properties":18},{"id":234,"createTime":235,"updateTime":235,"relativeEntities":274,"slug":18,"properties":275,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":276},{"VI":239},{"title":278},{"VI":279},"Hadeer S. Harb",{"id":281,"sortIndex":115,"researcher":18,"roles":282,"affiliations":283,"properties":292},"0f20e425-351c-4d6e-ac9e-7ff486e8fd4f",[117],[284],{"id":18,"sortIndex":19,"affiliation":285,"properties":18},{"id":286,"createTime":287,"updateTime":287,"relativeEntities":288,"slug":18,"properties":289,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"31d15b4b-5b65-4832-8026-4ec898a2f494","2023-12-12T08:52:55.492+00:00",[],{"title":290},{"VI":291},"Clinical Pharmacology Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt",{"title":293},{"VI":294},"Ahmed A. Elberry",{"url":210,"publisher":296,"properties":318},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":297,"slug":10,"properties":298,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":301,"manageAffiliations":302,"indexDatabases":303,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":299,"title":300},{"VOID":13},{"EN":15},[],[],[304,311],{"id":73,"indexDatabase":305,"url":86,"indexYears":87,"academicFieldIds":310,"indexDatabaseRanking":90},{"id":75,"createTime":76,"updateTime":77,"relativeEntities":306,"label":307,"description":308,"key":83,"publicationTags":309,"standard":18},[],{"EN":80,"VI":80},{"EN":80,"VI":82},[85],[89],{"id":54,"indexDatabase":312,"url":69,"indexYears":18,"academicFieldIds":317,"indexDatabaseRanking":18},{"id":56,"createTime":57,"updateTime":58,"relativeEntities":313,"label":314,"description":315,"key":65,"publicationTags":316,"standard":18},[],{"EN":61,"VI":61},{"VI":63,"EN":64},[67,68],[71],{"volume":319,"pages":321},{"VOID":320},"40",{"VOID":322},"28-34","2017-08-01",2017,{"id":326,"createTime":327,"updateTime":328,"relativeEntities":329,"slug":330,"properties":331,"entityType":108,"verifyStatus":109,"verifyTime":328,"verifyNote":110,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":338,"fullTextUrl":18,"authors":339,"publicationType":165,"publisherRelationship":379,"citationCount":18,"citationInfo":18,"publishDate":407,"publishYear":408,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":196},"1b4eff07-e278-4d4c-9c1e-7589c7912069","2024-01-13T15:00:20.830+00:00","2025-01-15T23:59:05.000+00:00",[],"Using-natural-excipients-to-enhance-the-solubility-of-the-poorly-water-soluble-antiretroviral-efavirenz",{"references":332,"title":334,"doi":336},{"VOID":333},"Adkins, 1998, Efavirenz. Drugs, 56, 1055, 10.2165\u002F00003495-199856060-00014\nRakhmanina, 2010, Efavirenz in the therapy of HIV infection, Expet Opin. Drug Metabol. Toxicol., 6, 95, 10.1517\u002F17425250903483207\nMerisko-Liversidge, 2008, Drug nanoparticles: formulating poorly water-soluble compounds, Toxicol. Pathol., 36, 43, 10.1177\u002F0192623307310946\nChadha, 2012, Effect of hydrophilic polymer on complexing efficiency of cyclodextrins towards efavirenz-characterization and thermodynamic parameters, J. Inclusion Phenom. Macrocycl. Chem., 72, 275, 10.1007\u002Fs10847-011-9972-z\nMazonde, 2020, Design, optimization, manufacture and characterization of efavirenz-loaded flaxseed oil nanoemulsions, Pharmaceutics, 12, 797, 10.3390\u002Fpharmaceutics12090797\nChiappetta, 2010, A highly concentrated and taste-improved aqueous formulation of efavirenz for a more appropriate pediatric management of the anti-HIV therapy, Curr. HIV Res., 8, 223, 10.2174\u002F157016210791111142\nMabrouk, 2015, Design of a novel crosslinked HEC-PAA porous hydrogel composite for dissolution rate and solubility enhancement of efavirenz, Int. J. Pharm., 490, 429, 10.1016\u002Fj.ijpharm.2015.05.082\nPawar, 2016, Solubility and dissolution enhancement of efavirenz hot melt extruded amorphous solid dispersions using combination of polymeric blends: a QbD approach, Eur. J. Pharmaceut. Sci., 88, 37, 10.1016\u002Fj.ejps.2016.04.001\nReddy, 2014, Solubility enhancement of poorly water soluble drug efavirenz by solid self emulsifying drug delivery systems, Int. J. Pharm. Rev. Res., 3, 20\nTaneja, 2016, Formulation and optimization of efavirenz nanosuspensions using the precipitation-ultrasonication technique for solubility enhancement, Artif. Cell Nanomed. Biotechnol., 44, 978\nMakoni, 2020, Preformulation studies of efavirenz with lipid excipients using thermal and spectroscopic techniques, Pharmazie, 75, 417\nRosen, 2012, 1\nBhosale, 2014, Natural gums and mucilages: a review on multifaceted excipients in pharmaceutical science and research, Int. J. Pharmacogn. Phytochem. Res., 6, 901\nChoudhary, 2014, Recently investigated natural gums and mucilages as pharmaceutical excipients: an overview, J. Pharm. (Lahore), 1–9\nFood and Drug Administration. 2019a. GRAS Notice No. 849. https:\u002F\u002Fwww.fda.gov\u002Fmedia\u002F135320\u002Fdownload. Date accessed: 03 Feb 2022..\nFood and Drug Administration. 2019b. GRAS Notice No. 849. https:\u002F\u002Fwww.fda.gov\u002Fmedia\u002F135320\u002Fdownload. Date accessed: 03 Feb 2022.\nBracco, 2013, Contact angle and wetting properties, 3\nWorld Health Organization, 2019, Dissolution test for solid oral dosage forms, 1\nSingh, 2013, Development and characterization of taste masked Efavirenz pellets utilizing hot melt extrusion, J. Drug Deliv. Sci. Technol., 23, 157, 10.1016\u002FS1773-2247(13)50024-4\nVitez, 1998, The evolution of hot-stage microscopy to aid solid-state characterizations of pharmaceutical solids, Thermochim. Acta, 324, 187, 10.1016\u002FS0040-6031(98)00535-8\nFandaruff, 2014, Thermal behavior and decomposition kinetics of efavirenz under isothermal and non-isothermal conditions, J. Therm. Anal. Calorim., 115, 2351, 10.1007\u002Fs10973-013-3306-x\nWardhana, 2020, Kinetic estimation of solid state transition during isothermal and grinding processes among efavirenz polymorphs, Heliyon, 6, 10.1016\u002Fj.heliyon.2020.e03876\nFandaruff, 2014, Polymorphism of anti-HIV drug efavirenz: investigations on thermodynamic and dissolution properties, Cryst. Growth Des., 14, 4968, 10.1021\u002Fcg500509c\nFernandes, 2016, Cashew gum and inulin: new alternative for ginger essential oil microencapsulation, Carbohydr. Polym., 153, 133, 10.1016\u002Fj.carbpol.2016.07.096\nLan, 2019, Solid dispersion-based spray-drying improves solubility and mitigates beany flavour of pea protein isolate, Food Chem., 278, 665, 10.1016\u002Fj.foodchem.2018.11.074\nRonkart, 2007, Characterization of the physical state of spray-dried inulin, Food Biophys., 2, 83, 10.1007\u002Fs11483-007-9034-7\nTamnak, 2016, Physicochemical properties, rheological behavior and morphology of pectin-pea protein isolate mixtures and conjugates in aqueous system and oil in water emulsion, Food Hydrocol., 56, 405, 10.1016\u002Fj.foodhyd.2015.12.033\nAlsenz, 2007, High throughput solubility measurement in drug discovery and development, Adv. Drug Deliv. Rev., 59, 546, 10.1016\u002Fj.addr.2007.05.007\nBasalious, 2011, Application of pharmaceutical QbD for enhancement of the solubility and dissolution of a class II BCS drug using polymeric surfactants and crystallization inhibitors: development of controlled-release tablets, AAPS PharmSciTech, 12, 799, 10.1208\u002Fs12249-011-9646-6\nVogt, 2008, Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations, Eur. J. Pharm. Biopharm., 68, 283, 10.1016\u002Fj.ejpb.2007.05.010\nZarmpi, 2020, Biopharmaceutical understanding of excipient variability on drug apparent solubility based on drug physicochemical properties. Case study: superdisintegrants, AAPS J., 22, 1\nMuster, 2005, Water adsorption kinetics and contact angles of pharmaceutical powders, J. Pharmacol. Sci., 94, 861, 10.1002\u002Fjps.20296\nKawabata, 2011, Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications, Int. J. Pharm., 420, 1, 10.1016\u002Fj.ijpharm.2011.08.032\nPouton, 2006, Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system, Eur. J. Pharmaceut. Sci., 29, 278, 10.1016\u002Fj.ejps.2006.04.016\nAlves, 2014, Solid dispersion of efavirenz in PVP K-30 by conventional solvent and kneading methods, Carbohydr. Polym., 104, 166, 10.1016\u002Fj.carbpol.2014.01.027\nG Rajurkar, 2015, Tablet formulation and enhancement of aqueous solubility of efavirenz by solvent evaporation Co-crystal technique. Med. Chem, (Los. Angeles), 10.4172\u002F2161-0444.1000002\nSathigari, 2009, Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes, AAPS PharmSciTech, 10, 81, 10.1208\u002Fs12249-008-9180-3\nPinto, 2014, Development of a discriminative intrinsic dissolution method for efavirenz, Dissolution Technol., 21, 31, 10.14227\u002FDT210214P31\nBarclay, 2010, Inulin - a versatile polysaccharide with multiple pharmaceutical and food chemical uses, J. Excipients Food Chem., 1, 27\nMensink, 2015, Inulin, a flexible oligosaccharide. II: review of its pharmaceutical applications, Carbohydr. Polym., 134, 418, 10.1016\u002Fj.carbpol.2015.08.022\nLi, 2013, Both solubility and chemical stability of curcumin are enhanced by solid dispersion in cellulose derivative matrices, Carbohydr. Polym., 98, 1108, 10.1016\u002Fj.carbpol.2013.07.017\nWan, 2012, Improved bioavailability of poorly water-soluble drug curcumin in cellulose acetate solid dispersion, AAPS PharmSciTech, 13, 159, 10.1208\u002Fs12249-011-9732-9\nDoan, 2019, Formation and stability of pea proteins nanoparticles using ethanol-induced desolvation, Nanomaterials, 9, 10.3390\u002Fnano9070949\nKundu, 2001, Effect of salts and surfactant and their doses on the gelation of extremely dilute solutions of methyl cellulose, Polymer, 42, 2015, 10.1016\u002FS0032-3861(00)00506-1\nPrasad, 2005, On the properties of agar gel containing ionic and non-ionic surfactants, Int. J. Biol. Macromol., 35, 135, 10.1016\u002Fj.ijbiomac.2005.01.004\nPiñero, 2018, In silico models in drug development: where we are, Curr. Opin. Pharmacol., 42, 111, 10.1016\u002Fj.coph.2018.08.007\nDas, 2020, Multiple approaches for achieving drug solubility: an in silico perspective, Drug Discov. Today, 25, 1206, 10.1016\u002Fj.drudis.2020.04.016",{"EN":335},"Using natural excipients to enhance the solubility of the poorly water-soluble antiretroviral, efavirenz",{"VOID":337},"10.1016\u002Fj.jddst.2022.103332","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1773224722002428",[340,355,367],{"id":341,"sortIndex":115,"researcher":18,"roles":342,"affiliations":343,"properties":352},"8646b73f-443b-4694-85b8-fc6761438127",[117],[344],{"id":18,"sortIndex":19,"affiliation":345,"properties":18},{"id":346,"createTime":347,"updateTime":347,"relativeEntities":348,"slug":18,"properties":349,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"af6a4359-194a-4e95-8751-74f915d43d24","2024-01-13T15:00:20.980+00:00",[],{"title":350},{"VI":351},"School of Pharmacy, Faculty of Science, University of the Western Cape, Cape Town, Bellville, 7353, South Africa",{"title":353},{"VI":354},"Halima Samsodien",{"id":356,"sortIndex":154,"researcher":18,"roles":357,"affiliations":358,"properties":364},"b440b27e-e96a-40f1-a529-ec396eedf1e3",[117],[359],{"id":18,"sortIndex":19,"affiliation":360,"properties":18},{"id":346,"createTime":347,"updateTime":347,"relativeEntities":361,"slug":18,"properties":362,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":363},{"VI":351},{"title":365},{"VI":366},"Marique Elizabeth Aucamp",{"id":368,"sortIndex":19,"researcher":18,"roles":369,"affiliations":370,"properties":376},"886a1829-51b8-4acb-8631-f0afe001e168",[117],[371],{"id":18,"sortIndex":19,"affiliation":372,"properties":18},{"id":346,"createTime":347,"updateTime":347,"relativeEntities":373,"slug":18,"properties":374,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":375},{"VI":351},{"title":377},{"VI":378},"Marise Nel",{"url":338,"publisher":380,"properties":402},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":381,"slug":10,"properties":382,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":385,"manageAffiliations":386,"indexDatabases":387,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":383,"title":384},{"VOID":13},{"EN":15},[],[],[388,395],{"id":73,"indexDatabase":389,"url":86,"indexYears":87,"academicFieldIds":394,"indexDatabaseRanking":90},{"id":75,"createTime":76,"updateTime":77,"relativeEntities":390,"label":391,"description":392,"key":83,"publicationTags":393,"standard":18},[],{"EN":80,"VI":80},{"EN":80,"VI":82},[85],[89],{"id":54,"indexDatabase":396,"url":69,"indexYears":18,"academicFieldIds":401,"indexDatabaseRanking":18},{"id":56,"createTime":57,"updateTime":58,"relativeEntities":397,"label":398,"description":399,"key":65,"publicationTags":400,"standard":18},[],{"EN":61,"VI":61},{"VI":63,"EN":64},[67,68],[71],{"volume":403,"pages":405},{"VOID":404},"71",{"VOID":406},"103332","2022-05-01",2022,{"id":410,"createTime":411,"updateTime":412,"relativeEntities":413,"slug":414,"properties":415,"entityType":108,"verifyStatus":109,"verifyTime":412,"verifyNote":110,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":422,"fullTextUrl":18,"authors":423,"publicationType":165,"publisherRelationship":522,"citationCount":18,"citationInfo":18,"publishDate":407,"publishYear":408,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":196},"f2ba1901-926d-4187-ab13-10fafddde805","2024-01-01T12:46:02.596+00:00","2025-02-09T23:54:50.536+00:00",[],"An-update-on-solid-state-characterization-of-the-polyphenol-pterostilbene",{"references":416,"title":418,"doi":420},{"VOID":417},"McCormack, 2013, A review of pterostilbene antioxidant activity and disease modification, Oxid. Med. Cell. Longev., 2013, 10.1155\u002F2013\u002F575482\nLin, 2020, Occurrence, bioavailability, anti-inflammatory, and anticancer effects of pterostilbene, J. Agric. Food Chem., 68, 12788, 10.1021\u002Facs.jafc.9b07860\nTsai, 2017, Biological actions and molecular effects of resveratrol, pterostilbene, and 3 '-hydroxypterostilbene, J. Food Drug Anal., 25, 134, 10.1016\u002Fj.jfda.2016.07.004\nKoh, 2021, Recent advances in health benefits of stilbenoids, J. Agric. Food Chem., 69, 10036, 10.1021\u002Facs.jafc.1c03699\nKim, 2020, Chemistry of pterostilbene and its metabolic effects, J. Agric. Food Chem., 68, 12836, 10.1021\u002Facs.jafc.0c00070\nRiche, 2013, Analysis of safety from a human clinical trial with pterostilbene, J. Toxicol., 2013, 10.1155\u002F2013\u002F463595\nSavjani, 2012, Drug solubility: importance and enhancement techniques, ISRN Pharmaceutics, 2012, 1, 10.5402\u002F2012\u002F195727\nLang, 2013, Polymorph screening of an active material, J. Pharmaceut. Biomed. Anal., 84, 177, 10.1016\u002Fj.jpba.2013.06.002\nSzabo, 2016, The role of solid state characterization in predicting stability of solid dosage forms, Curr. Pharmaceut. Des., 22, 5019, 10.2174\u002F1381612822666160726094236\nRodriguez-Aller, 2015, Strategies for formulating and delivering poorly water-soluble drugs, J. Drug Deliv. Sci. Technol., 30, 342, 10.1016\u002Fj.jddst.2015.05.009\nSorrenti, 2012, Solid-state characterization of tacrine hydrochloride, J. Pharmaceut. Biomed. Anal., 63, 53, 10.1016\u002Fj.jpba.2011.12.023\nMahesh, 2010, 1\nGottumukkala, 2013, 1\nRossi, 2013, Scavenging of hydroxyl radical by resveratrol and related natural stilbenes after hydrogen peroxide attack on DNA, Chem. Biol. Interact., 206, 175, 10.1016\u002Fj.cbi.2013.09.013\nBofill, 2019, Hydrogen bond polarization overcomes unfavorable packing in the most stable high Z ' polymorph of pterostilbene, Cryst. Growth Des., 19, 2552, 10.1021\u002Facs.cgd.9b00374\nBofill, 2020, A late appearing polymorph of nutraceutical pterostilbene, CrystEngComm, 22, 4680, 10.1039\u002FD0CE00837K\nSree Rambabu, 2013, 1\nSchultheiss, 2010, Nutraceutical cocrystals: utilizing pterostilbene as a cocrystal former, CrystEngComm, 12, 2436, 10.1039\u002Fc002045a\nBethune, 2011, Improving the poor aqueous solubility of nutraceutical compound pterostilbene through cocrystal formation, Cryst. Growth Des., 11, 2817, 10.1021\u002Fcg1016092\nBofill, 2021, A novel, extremely bioavailable cocrystal of pterostilbene, Cryst. Growth Des., 21, 2315, 10.1021\u002Facs.cgd.0c01716\nAaltonen, 2008, Perspectives in the use of spectroscopy to characterise pharmaceutical solids, Int. J. Pharm., 364, 159, 10.1016\u002Fj.ijpharm.2008.04.043\nThrelfall, 2000, Crystallisation of polymorphs: thermodynamic insight into the role of solvent, Org. Process Res. Dev., 4, 384, 10.1021\u002Fop000058y\nKitamura, 2009, Strategy for control of crystallization of polymorphs, CrystEngComm, 11, 949, 10.1039\u002Fb809332f\nCruz, 2019, Application of selective crystallization methods to isolate the metastable polymorphs of paracetamol: a review, Org. Process Res. Dev., 23, 2592, 10.1021\u002Facs.oprd.9b00322",{"EN":419},"An update on solid-state characterization of the polyphenol pterostilbene",{"VOID":421},"10.1016\u002Fj.jddst.2022.103331","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1773224722002416",[424,441,458,473,485,497,509],{"id":425,"sortIndex":40,"researcher":18,"roles":426,"affiliations":427,"properties":438},"a886f507-f7e6-43ea-90ba-14297e282695",[117],[428],{"id":18,"sortIndex":19,"affiliation":429,"properties":18},{"id":430,"createTime":431,"updateTime":432,"relativeEntities":433,"slug":434,"properties":435,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"0c1f37d2-cb0f-45c4-ac96-8ac08b230058","2024-01-22T08:31:04.275+00:00","2025-06-12T00:57:31.010+00:00",[],"Centre-for-Supramolecular-Chemistry-Research-Department-of-Chemistry-University-of-Cape-Town-Rondebosch-7701-South-Africa",{"title":436},{"VI":437},"Centre for Supramolecular Chemistry Research, Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa",{"title":439},{"VI":440},"Mino R. Caira",{"id":442,"sortIndex":214,"researcher":18,"roles":443,"affiliations":444,"properties":455},"b584dfc9-c463-4c4d-9671-dc4f834956d3",[117],[445],{"id":18,"sortIndex":19,"affiliation":446,"properties":18},{"id":447,"createTime":448,"updateTime":449,"relativeEntities":450,"slug":451,"properties":452,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"c7d2dc4a-3a1e-48fb-80e5-a376242f12c4","2023-12-23T21:42:32.461+00:00","2024-11-26T06:01:50.143+00:00",[],"Department-of-Drug-Sciences-University-of-Pavia-Viale-Taramelli-12-27100-Pavia-Italy",{"title":453},{"VI":454},"Department of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy",{"title":456},{"VI":457},"Caterina Valentino",{"id":459,"sortIndex":154,"researcher":18,"roles":460,"affiliations":461,"properties":470},"9d58099e-6227-4794-9cf6-9cca118980f3",[117],[462],{"id":18,"sortIndex":19,"affiliation":463,"properties":18},{"id":464,"createTime":465,"updateTime":465,"relativeEntities":466,"slug":18,"properties":467,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"8942741d-9da2-4854-ac8c-4ec2214ff7aa","2024-01-03T11:27:26.180+00:00",[],{"title":468},{"VI":469},"Department of Chemistry, University of Pavia, Viale Taramelli 14, 27100 Pavia, Italy",{"title":471},{"VI":472},"Chiara Milanese",{"id":474,"sortIndex":245,"researcher":18,"roles":475,"affiliations":476,"properties":482},"0a5aadac-0971-43a2-946d-2ddc51f50073",[117],[477],{"id":18,"sortIndex":19,"affiliation":478,"properties":18},{"id":430,"createTime":431,"updateTime":432,"relativeEntities":479,"slug":434,"properties":480,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":481},{"VI":437},{"title":483},{"VI":484},"Alexios I. Vicatos",{"id":486,"sortIndex":19,"researcher":18,"roles":487,"affiliations":488,"properties":494},"1d12891e-2db1-4bbc-a312-f542bd87b693",[117],[489],{"id":18,"sortIndex":19,"affiliation":490,"properties":18},{"id":447,"createTime":448,"updateTime":449,"relativeEntities":491,"slug":451,"properties":492,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":493},{"VI":454},{"title":495},{"VI":496},"Laura Catenacci",{"id":498,"sortIndex":115,"researcher":18,"roles":499,"affiliations":500,"properties":506},"0783c4df-2ea2-47e9-9774-5fc4f5507cc0",[117],[501],{"id":18,"sortIndex":19,"affiliation":502,"properties":18},{"id":447,"createTime":448,"updateTime":449,"relativeEntities":503,"slug":451,"properties":504,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":505},{"VI":454},{"title":507},{"VI":508},"Milena Sorrenti",{"id":510,"sortIndex":511,"researcher":18,"roles":512,"affiliations":513,"properties":519},"598a0082-2bf3-45e2-8177-94b9d22af86e",6,[117],[514],{"id":18,"sortIndex":19,"affiliation":515,"properties":18},{"id":447,"createTime":448,"updateTime":449,"relativeEntities":516,"slug":451,"properties":517,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":518},{"VI":454},{"title":520},{"VI":521},"Maria Cristina Bonferoni",{"url":422,"publisher":523,"properties":545},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":524,"slug":10,"properties":525,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":528,"manageAffiliations":529,"indexDatabases":530,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":526,"title":527},{"VOID":13},{"EN":15},[],[],[531,538],{"id":73,"indexDatabase":532,"url":86,"indexYears":87,"academicFieldIds":537,"indexDatabaseRanking":90},{"id":75,"createTime":76,"updateTime":77,"relativeEntities":533,"label":534,"description":535,"key":83,"publicationTags":536,"standard":18},[],{"EN":80,"VI":80},{"EN":80,"VI":82},[85],[89],{"id":54,"indexDatabase":539,"url":69,"indexYears":18,"academicFieldIds":544,"indexDatabaseRanking":18},{"id":56,"createTime":57,"updateTime":58,"relativeEntities":540,"label":541,"description":542,"key":65,"publicationTags":543,"standard":18},[],{"EN":61,"VI":61},{"VI":63,"EN":64},[67,68],[71],{"volume":546,"pages":547},{"VOID":404},{"VOID":548},"103331",{"id":550,"createTime":551,"updateTime":551,"relativeEntities":552,"slug":553,"properties":554,"entityType":108,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":561,"fullTextUrl":18,"authors":562,"publicationType":165,"publisherRelationship":652,"citationCount":18,"citationInfo":18,"publishDate":407,"publishYear":408,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":196},"7bb72d4c-0cd1-4407-b9e1-b98a0513a5ae","2023-11-24T23:54:32.003+00:00",[],"Formulation-and-evaluation-of-different-hydrogels-loaded-with-Florite-based-etodolac-adsorbate-In-vitro-and-in-vivo-correlation",{"references":555,"title":557,"doi":559},{"VOID":556},"Inoue, 2011, The enantiomers of etodolac, a racemic anti-inflammatory agent, play different roles in efficacy and gastrointestinal safety, Biol. Pharm. Bull., 34, 655, 10.1248\u002Fbpb.34.655\nSerajuddin, 1999, Solid dispersion of poorly water‐soluble drugs: early promises, subsequent problems, and recent breakthroughs, J. Pharmaceut. Sci., 88, 1058, 10.1021\u002Fjs980403l\nShilakari Asthana, 2016, Etodolac containing topical niosomal gel: formulation development and evaluation, J. Drug Deliv., 1, 10.1155\u002F2016\u002F9324567\nBanker, 2002\nSabale, 2012, Formulation and evaluation of microemulsion-based hydrogel for topical delivery, Int. J.Pharmaceut. Invest., 2, 140, 10.4103\u002F2230-973X.104397\nPal, 2009, Polymeric hydrogels: characterization and biomedical applications, Des. Monomers Polym., 12, 197, 10.1163\u002F156855509X436030\nArakelova, 2013\nAhmed, 2015, Hydrogel: preparation, characterization, and applications: a review, J. Adv. Res., 6, 105, 10.1016\u002Fj.jare.2013.07.006\nCharoenchaitrakool, 2000, Micronization by rapid expansion of supercritical solutions to enhance the dissolution rates of poorly water-soluble pharmaceuticals, J. Ind. Eng.Chem. Res., 39, 4794, 10.1021\u002Fie000151a\nKomala, 2015, Competence of raloxifene hydrochloride loaded liquisolid compacts for improved dissolution and intestinal permeation, J. Drug Deliv. Sci. Technol., 30, 232, 10.1016\u002Fj.jddst.2015.10.020\nWempe, 2008, Pharmacokinetics of raloxifene in male Wistar–Hannover rats: influence of complexation with hydroxybutenyl-beta-cyclodextrin, Int. J. Pharm., 346, 25, 10.1016\u002Fj.ijpharm.2007.06.002\nRavi, 2014, Lipid nanoparticles for oral delivery of raloxifene: optimization, stability, in vivo evaluation and uptake mechanism, Eur. J. Pharm. Biopharm., 87, 114, 10.1016\u002Fj.ejpb.2013.12.015\nElsheikh, 2012, Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal, Int. J. Nanomed., 7, 3787\nZayed, 2014, Dissolution rate enhancement of ketoprofen by surface solid dispersion with colloidal silicon dioxide, Unique. J. Pharmaceut. Biol. Chem., 1, 33\nLaw, 1990, Improving dissolution rates of griseofulivin by deposition on disintegrants, Drug Dev. Ind. Pharm., 16, 137, 10.3109\u002F03639049009115990\nLaw, 1990, Improving dissolution rates of griseofulivin by deposition on disintegrants, Drug Dev. Ind. Pharm., 16, 137, 10.3109\u002F03639049009115990\nIsmail, 2004, Preparation and evaluation of naproxen adsorbate as an attempt to improve drug dissolution characteristics, Bull. Pharmaceut.Sci.Assiut, 27, 53, 10.21608\u002Fbfsa.2004.65408\nChella, 2012, Use of the liquisolid compact technique for improvement of the dissolution rate of valsartan, Acta Pharm. Sin. B, 2, 502, 10.1016\u002Fj.apsb.2012.07.005\nSrikanth, 2013, Dissolution rate enhancement of bicalutamide by adsorption process, Afr. J.Pharm. Pharmacol, 7, 1357, 10.5897\u002FAJPP10.073\nPutra, 2009, Performance of activated carbon and bentonite for adsorption of amoxicillin from wastewater: mechanisms, isotherms and kinetics, J. Water .Res., 43, 2419, 10.1016\u002Fj.watres.2009.02.039\nQian, 2012, Application of mesoporous silicon dioxide and silicate in oral amorphous drug delivery systems, J. Pharmaceut. Sci., 101, 444, 10.1002\u002Fjps.22779\nMahajan, 2018, Solid dispersion adsorbate technique for improved dissolution and flow properties of lurasidone hydrochloride: characterization using 32 factorial design, J.Drug.Dev. Ind. Pharm., 44, 463, 10.1080\u002F03639045.2017.1397687\nIbrahim, 2010, Formulation and evaluation of ketorolac tromethamine-Eudragit solid dispersions of potential sustained-release properties, STP Pharma Prat., 20, 189\nIsmail, 2009, Enhancement of solubility and dissolution of nimesulide using solubilization, solid dispersion and complexation techniques, Bull. Pharmaceut.Sci.Assiut, 32, 321, 10.21608\u002Fbfsa.2009.63509\nKumar, 2006, Preparation, characterization and in vitro dissolution studies of solid dispersion of Meloxicam with PEG 60001, Yakugaku Zasshi, 126, 657, 10.1248\u002Fyakushi.126.657\nCoviello, 2007, Polysaccharide hydrogels for modified release formulations, J. Contr. Release, 119, 5, 10.1016\u002Fj.jconrel.2007.01.004\nTas, 2003, In vitro release studies of chlorpheniramine maleate from gels prepared by different cellulose derivatives, Il Farmaco, 58, 605, 10.1016\u002FS0014-827X(03)00080-6\nIslam, 2004, Rheological characterization of topical carbomer gels neutralized to different pH, J. Pharmaceut. Res., 21, 1192, 10.1023\u002FB:PHAM.0000033006.11619.07\nYapar, 2013, Design and in vivo evaluation of emulgel formulations including green tea extract and rose oil, Acta Pharm., 63, 531, 10.2478\u002Facph-2013-0037\nSiewert, 2003, FIP\u002FAAPS guidelines to dissolution\u002Fin vitro release testing of novel\u002Fspecial dosage forms, AAPS PharmSciTech, 4, 43, 10.1208\u002Fpt040107\nWinter, 1962, Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs, Exp. Biol. Med., 111, 544, 10.3181\u002F00379727-111-27849\nHabiba, 2014, Different topical formulations of ketorolac tromethamine for anti-inflammatory application and clinical efficacy, Digest J.Nanomater.Biostructures, 9, 705\nWinter, 1963, Anti-inflammatory and antipyretic activities of indo-methacin, 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-indole-3-acetic acid, J. Pharmacol. Exp. Therapeut., 141, 369\nDraize, 1944, Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes, J. Pharmacol. Exp. Therapeut., 82, 377\nDwivedi, 2010, Quantum chemical study of etodolac (lodine), Der Pharma Chem., 2, 58\nFlorey, 1981\nAbdelbary, 2013, Influence of various polymers on the improvement of etodolac solubility and dissolution rate via. Solid dispersion technique, Inven. Impact Pharm. Tech., 2013, 1\nIsmail, 2009, Enhancement of solubility and dissolution of nimesulide using solubilization, solid dispersion and complexation techniques, Bull. Pharmaceut.Sci.Assiut, 32, 321, 10.21608\u002Fbfsa.2009.63509\nTerinte, 2011, Overview on native cellulose and microcrystalline cellulose I structure studied by X-ray diffraction (WAXD): comparison between measurement techniques, Lenzinger Berichte, 89, 118\nQian, 2010, Drug–polymer solubility and miscibility: stability consideration and practical challenges in amorphous solid dispersion development, J. Pharmaceut. Sci., 99, 2941, 10.1002\u002Fjps.22074\nKawano, 2021, Solubility enhancement of Ibuprofen by adsorption onto spherical porous calcium silicate, Pharmaceutics, 13, 767, 10.3390\u002Fpharmaceutics13060767\nPlaninšek, 2011, Carvedilol dissolution improvement by preparation of solid dispersions with porous silica, Int. J. Pharm., 406, 41, 10.1016\u002Fj.ijpharm.2010.12.035\nAli, 1992, Molecular behavior of Flufenamic acid in physical and ground mixtures with florite, Chem. Pharm. Bull., 40, 1289, 10.1248\u002Fcpb.40.1289\nAli, 1997, Enhancement of dissolution rate of carbamazepine: In vitro studies, Chem. Pharm. Bull. Pharm. Sci., 20, 1\nCleary, 2019, 203\nYapar, 2013, Design and in vivo evaluation of emulgel formulations including green tea extract and rose oil, Acta Pharm., 63, 531, 10.2478\u002Facph-2013-0037\nSaroha, 2013, Transdermal gels- an alternative vehicle for drug delivery, Int. J. Pharmaceut. Chem. Biol. Sci., 3\nKinoshita, 2002, Improvement of solubility and oral bioavailability of a poorly water-soluble drug, TAS-301, by its melt-adsorption on a porous calcium silicate, J Pharm Sci, 91, 362, 10.1002\u002Fjps.10026\nMehrabifar, 2017, Significany increasing of gastrointestinal dissolution of aceclofenac via Florite, MedBioTech J, 1, 9\nSaarai, 2012, On the characterization of sodium alginate\u002Fgelatine‐based hydrogels for wound dressing, J. Appl. Polym. Sci., 126, E79, 10.1002\u002Fapp.36590\nRitger, 1987, A simple equation for description of solute release II. Fickian and anomalous release from swellable devices, J. Contr. Release, 5, 37, 10.1016\u002F0168-3659(87)90035-6\nAuda, 2015, In-vitro release and in-vivo performance of tolmetin from different topical gel formulations, J.Pharmaceut.Invest., 45, 311, 10.1007\u002Fs40005-015-0174-3\nWinter, 1962, Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs, Exp. Biol. Med., 111, 544, 10.3181\u002F00379727-111-27849",{"EN":558},"Formulation and evaluation of different hydrogels loaded with Florite®-based etodolac adsorbate: In vitro and in vivo correlation",{"VOID":560},"10.1016\u002Fj.jddst.2022.103304","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1773224722002143",[563,578,590,602,628,640],{"id":564,"sortIndex":19,"researcher":18,"roles":565,"affiliations":566,"properties":575},"5ffc575c-1e18-4478-a631-5dc513738dd4",[117],[567],{"id":18,"sortIndex":19,"affiliation":568,"properties":18},{"id":569,"createTime":570,"updateTime":570,"relativeEntities":571,"slug":18,"properties":572,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"195a6022-b82e-4f32-9e8e-e1e944d1d373","2023-12-06T23:36:40.581+00:00",[],{"title":573},{"VI":574},"Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Al-Azhar University, Assiut 71524, Egypt",{"title":576},{"VI":577},"Ahmed M. Mohammed",{"id":579,"sortIndex":245,"researcher":18,"roles":580,"affiliations":581,"properties":587},"ea7cdff1-ca75-4b35-82b6-54df8168d9ea",[117],[582],{"id":18,"sortIndex":19,"affiliation":583,"properties":18},{"id":569,"createTime":570,"updateTime":570,"relativeEntities":584,"slug":18,"properties":585,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":586},{"VI":574},{"title":588},{"VI":589},"Fahd M. Alsharif",{"id":591,"sortIndex":40,"researcher":18,"roles":592,"affiliations":593,"properties":599},"0624cf47-d942-473c-ae7a-f3bd100e3028",[117],[594],{"id":18,"sortIndex":19,"affiliation":595,"properties":18},{"id":569,"createTime":570,"updateTime":570,"relativeEntities":596,"slug":18,"properties":597,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":598},{"VI":574},{"title":600},{"VI":601},"Shaaban K. Osman",{"id":603,"sortIndex":214,"researcher":18,"roles":604,"affiliations":605,"properties":625},"eb8d7aa6-17d9-4fb3-a5b1-270781a41918",[117],[606,616],{"id":607,"sortIndex":115,"affiliation":608,"properties":615},"b6c1679a-dae0-4d59-b705-4cd5c5c6196d",{"id":609,"createTime":610,"updateTime":610,"relativeEntities":611,"slug":18,"properties":612,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"899cee85-03a1-47dc-b543-436c504dc79f","2023-12-12T03:51:10.601+00:00",[],{"title":613},{"VI":614},"Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, South Valley University, Qena, 83523, Egypt",{},{"id":18,"sortIndex":19,"affiliation":617,"properties":18},{"id":618,"createTime":619,"updateTime":619,"relativeEntities":620,"slug":621,"properties":622,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"cbb32a44-fe1d-4236-af02-e526fc883ac0","2023-11-24T23:54:32.025+00:00",[],"Department-of-Pharmaceutical-Sciences-College-of-Pharmacy-Shaqra-University-Shaqra-Saudi-Arabia",{"title":623},{"VI":624},"Department of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Shaqra, Saudi Arabia",{"title":626},{"VI":627},"Mohamed A. El Hamd",{"id":629,"sortIndex":154,"researcher":18,"roles":630,"affiliations":631,"properties":637},"ea022db5-c691-4385-99c1-0a6e287bde26",[117],[632],{"id":18,"sortIndex":19,"affiliation":633,"properties":18},{"id":618,"createTime":619,"updateTime":619,"relativeEntities":634,"slug":621,"properties":635,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":636},{"VI":624},{"title":638},{"VI":639},"Saud Almawash",{"id":641,"sortIndex":115,"researcher":18,"roles":642,"affiliations":643,"properties":649},"88ced8d0-f37d-4fcd-b1b8-e0233f50a498",[117],[644],{"id":18,"sortIndex":19,"affiliation":645,"properties":18},{"id":569,"createTime":570,"updateTime":570,"relativeEntities":646,"slug":18,"properties":647,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":648},{"VI":574},{"title":650},{"VI":651},"Khaled I. Saleh",{"url":561,"publisher":653,"properties":675},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":654,"slug":10,"properties":655,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":658,"manageAffiliations":659,"indexDatabases":660,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":656,"title":657},{"VOID":13},{"EN":15},[],[],[661,668],{"id":73,"indexDatabase":662,"url":86,"indexYears":87,"academicFieldIds":667,"indexDatabaseRanking":90},{"id":75,"createTime":76,"updateTime":77,"relativeEntities":663,"label":664,"description":665,"key":83,"publicationTags":666,"standard":18},[],{"EN":80,"VI":80},{"EN":80,"VI":82},[85],[89],{"id":54,"indexDatabase":669,"url":69,"indexYears":18,"academicFieldIds":674,"indexDatabaseRanking":18},{"id":56,"createTime":57,"updateTime":58,"relativeEntities":670,"label":671,"description":672,"key":65,"publicationTags":673,"standard":18},[],{"EN":61,"VI":61},{"VI":63,"EN":64},[67,68],[71],{"volume":676,"pages":677},{"VOID":404},{"VOID":678},"103304",{"id":680,"createTime":681,"updateTime":682,"relativeEntities":683,"slug":684,"properties":685,"entityType":108,"verifyStatus":109,"verifyTime":682,"verifyNote":110,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":692,"fullTextUrl":18,"authors":693,"publicationType":165,"publisherRelationship":757,"citationCount":18,"citationInfo":18,"publishDate":785,"publishYear":195,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":196},"fabb4b9a-078e-43f8-9fc2-a2ad64750f34","2024-01-02T02:55:38.655+00:00","2025-01-21T23:54:09.419+00:00",[],"Hydrophobically-modified-inulin-based-micelles-Transport-mechanisms-and-drug-delivery-applications-for-breast-cancer",{"references":686,"title":688,"doi":690},{"VOID":687},"Kesharwani, 2018\nKesharwani, 2018, Overcoming multiple drug resistance in cancer using polymeric micelles, Expert Opin. Drug Deliv., 15, 1127, 10.1080\u002F17425247.2018.1537261\nBae, 2011, Targeted drug delivery to tumors: myths, reality, and possibility, J. Control. Release, 153, 10.1016\u002Fj.jconrel.2011.06.001\nWang, 2009, Advances of cancer therapy by nanotechnology, Cancer Res. Treat: Off. J. Korean Cancer Assoc., 41, 10.4143\u002Fcrt.2009.41.1.1\nGlasgow, 2015, Recent developments in active tumor targeted multifunctional nanoparticles for combination chemotherapy in cancer treatment and imaging, J. Biomed. Nanotechnol., 11, 1859, 10.1166\u002Fjbn.2015.2145\nPeer, 2007, Nanocarriers as an emerging platform for cancer therapy, Nat. Nanotechnol., 2, 10.1038\u002Fnnano.2007.387\nFarokhzad, 2009, Impact of nanotechnology on drug delivery, ACS Nano, 3, 16, 10.1021\u002Fnn900002m\nKedar, 2010, Advances in polymeric micelles for drug delivery and tumor targeting, Nanomed. Nanotechnol. Biol. Med., 6, 714, 10.1016\u002Fj.nano.2010.05.005\nAlexis, 2010, 55\nXu, 2013, Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs, Journal of Drug Deliv, 2013, 10.1155\u002F2013\u002F340315\nGothwal, 2016, Polymeric micelles: recent advancements in the delivery of anticancer drugs, Pharm. Res., 33, 18, 10.1007\u002Fs11095-015-1784-1\nTrivedi, 2010, Nanomicellar formulations for sustained drug delivery: strategies and underlying principles, Nanomedicine, 5, 485, 10.2217\u002Fnnm.10.10\nKwon, 1996, Polymeric micelles as new drug carriers, Adv. Drug Deliv. Rev., 21, 107, 10.1016\u002FS0169-409X(96)00401-2\nBiswas, 2016, Recent advances in polymeric micelles for anti-cancer drug delivery, Eur. J. Pharm. Sci., 83, 184, 10.1016\u002Fj.ejps.2015.12.031\nSuk, 2016, PEGylation as a strategy for improving nanoparticle-based drug and gene delivery, Adv. Drug Deliv. Rev., 99, 28, 10.1016\u002Fj.addr.2015.09.012\nWang, 2018, Poly (Ethylene Glycol)–polylactide micelles for cancer therapy, Front. Pharmacol., 9\nGaray, 2012\nIshida, 2003, Accelerated clearance of PEGylated liposomes in rats after repeated injections, J. Control. Release, 88, 35, 10.1016\u002FS0168-3659(02)00462-5\nOtsuka, 2012, PEGylated nanoparticles for biological and pharmaceutical applications, Adv. Drug Deliv. Rev., 64, 246, 10.1016\u002Fj.addr.2012.09.022\nShiraishi, 2013, Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon, J. Control. Release, 165, 183, 10.1016\u002Fj.jconrel.2012.11.016\nJokerst, 2011, Nanoparticle PEGylation for imaging and therapy, Nanomedicine, 6, 715, 10.2217\u002Fnnm.11.19\nZhang, 2008, Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel, Biomaterials, 29, 1233, 10.1016\u002Fj.biomaterials.2007.11.029\nMo, 2011, The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles, Biomaterials, 32, 4609, 10.1016\u002Fj.biomaterials.2011.03.005\nSarika, 2015, Galactosylated pullulan–curcumin conjugate micelles for site specific anticancer activity to hepatocarcinoma cells, Colloids Surfaces B Biointerfaces, 133, 347, 10.1016\u002Fj.colsurfb.2015.06.020\nWang, 2014, Novel reduction-sensitive pullulan-based micelles with good hemocompatibility for efficient intracellular doxorubicin delivery, RSC Adv., 4, 60064, 10.1039\u002FC4RA12276C\nKafshgari, 2012, Preparation of alginate and chitosan nanoparticles using a new reverse micellar system, Iran. Polym. J. (Engl. Ed.), 21, 99, 10.1007\u002Fs13726-011-0010-1\nDu, 2010, Synthesis and antitumor activity of stearate-g-dextran micelles for intracellular doxorubicin delivery, ACS Nano, 4, 6894, 10.1021\u002Fnn100927t\nLiu, 2015, High tolerated paclitaxel nano-formulation delivered by poly (lactic-co-glycolic acid)-g-dextran micelles to efficient cancer therapy, Nanomed. Nanotechnol. Biol. Med., 11, 855, 10.1016\u002Fj.nano.2015.02.002\nMandracchia, 2018, pH-sensitive inulin-based nanomicelles for intestinal site-specific and controlled release of celecoxib, Carbohydr. Polym., 181, 570, 10.1016\u002Fj.carbpol.2017.11.110\nMandracchia, 2017, Design, synthesis and evaluation of biotin decorated inulin-based polymeric micelles as long-circulating nanocarriers for targeted drug delivery, Nanomed. Nanotechnol. Biol. Med., 13, 1245, 10.1016\u002Fj.nano.2017.01.001\nZhang, 2013, Polysaccharide-based micelles for drug delivery, Pharmaceutics, 5, 329, 10.3390\u002Fpharmaceutics5020329\nAumelas, 2007, Nanoparticles of hydrophobically modified dextrans as potential drug carrier systems, Colloids Surfaces B Biointerfaces, 59, 74, 10.1016\u002Fj.colsurfb.2007.04.021\nNamazi, 2011, Hydrophobically modified starch using long-chain fatty acids for preparation of nanosized starch particles, Sci. Iran., 18, 439\nYang, 2008, Self-aggregated nanoparticles from methoxy poly (ethylene glycol)-modified chitosan: synthesis; characterization; aggregation and methotrexate release in vitro, Colloids Surfaces B Biointerfaces, 61, 125, 10.1016\u002Fj.colsurfb.2007.07.012\nSallustio, 2004, Hydrophobically modified pullulans: characterization and physicochemical properties, J. Phys. Chem. B, 108, 18876, 10.1021\u002Fjp048068e\nMuley, 2016, Hydrophobically modified inulin as an amphiphilic carbohydrate polymer for micellar delivery of paclitaxel for intravenous route, Int. J pharm., 500, 32, 10.1016\u002Fj.ijpharm.2016.01.005\nMandracchia, 2014, Amphiphilic inulin-D-α-tocopherol succinate (INVITE) bioconjugates for biomedical applications, Carbohydr. Polym., 103, 46, 10.1016\u002Fj.carbpol.2013.11.056\nMandracchia, 2016, Inulin based micelles loaded with curcumin or celecoxib with effective anti-angiogenic activity, Eur. J. Pharm. Sci., 93, 141, 10.1016\u002Fj.ejps.2016.08.027\nDuan, 2013, Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking, Small, 9, 1521, 10.1002\u002Fsmll.201201390\nAvvakumova, 2014, Biotechnological approaches toward nanoparticle biofunctionalization, Trends Biotechnol., 32, 11, 10.1016\u002Fj.tibtech.2013.09.006\nDalal, 2016, Nanoparticle multivalency directed shifting of cellular uptake mechanism, J. Phys. Chem. C, 120, 6778, 10.1021\u002Facs.jpcc.5b11059\nKumar, 2016, Molecular complexation of curcumin with pH sensitive cationic copolymer enhances the aqueous solubility, stability and bioavailability of curcumin, Eur. J. Pharm. Sci., 82, 86, 10.1016\u002Fj.ejps.2015.11.010\nKumar, 2016, Discovery of inulin acetate as a novel immune-active polymer and vaccine adjuvant: synthesis, material characterization, and biological evaluation as a toll-like receptor-4 agonist, J. Mater. Chem. B, 4, 7950, 10.1039\u002FC6TB02181F\nKumar, 2017, Pathogen-mimicking vaccine delivery system designed with a bioactive polymer (inulin acetate) for robust humoral and cellular immune responses, J. Control. Release, 261, 263, 10.1016\u002Fj.jconrel.2017.06.026\nRajput, 2018, Dendritic cell-targeted nanovaccine delivery system prepared with an immune-active polymer, ACS Appl. Mater. Interfaces, 10, 27589, 10.1021\u002Facsami.8b02019\nHan, 2016, Bioerodable PLGA-based microparticles for producing sustained-release drug formulations and strategies for improving drug loading, Front. Pharmacol., 7, 10.3389\u002Ffphar.2016.00185\nKesharwani, 2018, Site-directed non-covalent polymer-drug complexes for inflammatory bowel disease (IBD): formulation development, characterization and pharmacological evaluation, J. Control. Release, 290, 165, 10.1016\u002Fj.jconrel.2018.08.004\nSahay, 2008, Different internalization pathways of polymeric micelles and unimers and their effects on vesicular transport, Bioconjug. Chem., 19, 2023, 10.1021\u002Fbc8002315\nLu, 2013, Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs, Int. J pharm., 453, 198, 10.1016\u002Fj.ijpharm.2012.08.042\nPrasad, 1979, Surface activity and association of ABA polyoxyethylene—polyoxypropylene block copolymers in aqueous solution, J. Colloid Interface Sci., 69, 225, 10.1016\u002F0021-9797(79)90151-6\nWang, 2012, In vitro evaluation of polymeric micelles based on hydrophobically-modified sulfated chitosan as a carrier of doxorubicin, J. Mater. Sci. Mater. Med., 23, 1663, 10.1007\u002Fs10856-012-4627-1\nWu, 2014, In vitro drug release and biological evaluation of biomimetic polymeric micelles self-assembled from amphiphilic deoxycholic acid–phosphorylcholine–chitosan conjugate, Mater. Sci. Eng. C, 45, 162, 10.1016\u002Fj.msec.2014.09.008\nFernando, 2010, Mechanism of cellular uptake of highly fluorescent conjugated polymer nanoparticles, Biomacromolecules, 11, 2675, 10.1021\u002Fbm1007103\nSalatin, 2017, Overviews on the cellular uptake mechanism of polysaccharide colloidal nanoparticles, J. Cell Mol. Med., 21, 1668, 10.1111\u002Fjcmm.13110\nYameen, 2014, Insight into nanoparticle cellular uptake and intracellular targeting, J. Control. Release, 190, 485, 10.1016\u002Fj.jconrel.2014.06.038\nBehzadi, 2017, Cellular uptake of nanoparticles: journey inside the cell, Chem. Soc. Rev., 46, 4218, 10.1039\u002FC6CS00636A\nMao, 2013, Influence of structure and properties of colloidal biomaterials on cellular uptake and cell functions, Biomater. Sci., 1, 896, 10.1039\u002Fc3bm00137g\nLiu, 2016, Carbohydrate-based amphiphilic nano delivery systems for cancer therapy, Nanoscale, 8, 16091, 10.1039\u002FC6NR04489A\nNitta, 2013, Biopolymer-based nanoparticles for drug\u002Fgene delivery and tissue engineering, Int. J. Mol. Sci., 14, 1629, 10.3390\u002Fijms14011629\nPosocco, 2015, Polysaccharides for the delivery of antitumor drugs, Materials, 8, 2569, 10.3390\u002Fma8052569",{"EN":689},"Hydrophobically modified inulin-based micelles: Transport mechanisms and drug delivery applications for breast cancer",{"VOID":691},"10.1016\u002Fj.jddst.2019.101254","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1773224719309827",[694,721,733,745],{"id":695,"sortIndex":19,"researcher":18,"roles":696,"affiliations":697,"properties":718},"c77f314e-d148-4be1-b52e-ada93574f29c",[117],[698,708],{"id":18,"sortIndex":19,"affiliation":699,"properties":18},{"id":700,"createTime":701,"updateTime":702,"relativeEntities":703,"slug":704,"properties":705,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"033f7baf-118f-4396-9deb-4c0bdb2cc7fd","2024-01-02T02:55:38.817+00:00","2025-06-11T16:36:05.300+00:00",[],"Department-of-Pharmaceutical-Sciences-South-Dakota-State-University-Box-2202C-Brookings-SD-57007-USA",{"title":706},{"VI":707},"Department of Pharmaceutical Sciences, South Dakota State University, Box 2202C, Brookings, SD, 57007, USA",{"id":709,"sortIndex":115,"affiliation":710,"properties":717},"3a17cf83-684b-445a-9924-a1fbc3349f3a",{"id":711,"createTime":712,"updateTime":712,"relativeEntities":713,"slug":18,"properties":714,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"413df723-43f6-46ee-af0a-8b5ad87c123a","2024-01-02T02:55:38.691+00:00",[],{"title":715},{"VI":716},"Roseman University of Health Sciences, College of Pharmacy, 10920 S. River Front Parkway, South Jordan, UT, 84095, USA",{},{"title":719},{"VI":720},"Siddharth S. Kesharwani",{"id":722,"sortIndex":154,"researcher":18,"roles":723,"affiliations":724,"properties":730},"33ec5c3a-70e5-4347-9dd1-fc8c2a5c6c53",[117],[725],{"id":18,"sortIndex":19,"affiliation":726,"properties":18},{"id":700,"createTime":701,"updateTime":702,"relativeEntities":727,"slug":704,"properties":728,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":729},{"VI":707},{"title":731},{"VI":732},"G. Jayarama Bhat",{"id":734,"sortIndex":214,"researcher":18,"roles":735,"affiliations":736,"properties":742},"e26e98e1-59a9-45e4-8efe-017827985e83",[117],[737],{"id":18,"sortIndex":19,"affiliation":738,"properties":18},{"id":700,"createTime":701,"updateTime":702,"relativeEntities":739,"slug":704,"properties":740,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":741},{"VI":707},{"title":743},{"VI":744},"Hemachand Tummala",{"id":746,"sortIndex":115,"researcher":18,"roles":747,"affiliations":748,"properties":754},"d57778c2-6b5d-4469-9854-ddb0895f291b",[117],[749],{"id":18,"sortIndex":19,"affiliation":750,"properties":18},{"id":700,"createTime":701,"updateTime":702,"relativeEntities":751,"slug":704,"properties":752,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":753},{"VI":707},{"title":755},{"VI":756},"Rakesh Dachineni",{"url":692,"publisher":758,"properties":780},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":759,"slug":10,"properties":760,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":763,"manageAffiliations":764,"indexDatabases":765,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":761,"title":762},{"VOID":13},{"EN":15},[],[],[766,773],{"id":73,"indexDatabase":767,"url":86,"indexYears":87,"academicFieldIds":772,"indexDatabaseRanking":90},{"id":75,"createTime":76,"updateTime":77,"relativeEntities":768,"label":769,"description":770,"key":83,"publicationTags":771,"standard":18},[],{"EN":80,"VI":80},{"EN":80,"VI":82},[85],[89],{"id":54,"indexDatabase":774,"url":69,"indexYears":18,"academicFieldIds":779,"indexDatabaseRanking":18},{"id":56,"createTime":57,"updateTime":58,"relativeEntities":775,"label":776,"description":777,"key":65,"publicationTags":778,"standard":18},[],{"EN":61,"VI":61},{"VI":63,"EN":64},[67,68],[71],{"volume":781,"pages":783},{"VOID":782},"54",{"VOID":784},"101254","2019-12-01",{"id":787,"createTime":788,"updateTime":789,"relativeEntities":790,"slug":791,"properties":792,"entityType":108,"verifyStatus":109,"verifyTime":789,"verifyNote":110,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":799,"fullTextUrl":18,"authors":800,"publicationType":165,"publisherRelationship":919,"citationCount":18,"citationInfo":18,"publishDate":947,"publishYear":948,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":196},"8d09aab1-26c5-40ce-8354-224e07d9bd1d","2023-12-02T11:51:58.374+00:00","2024-12-05T23:53:26.963+00:00",[],"Preparation-and-characterization-of-injectable-self-antibacterial-gelatin-carrageenan-bacterial-cellulose-hydrogel-scaffolds-for-wound-healing-application",{"references":793,"title":795,"doi":797},{"VOID":794},"Li, 2018, Zein\u002Fgum Arabic nanoparticle-stabilized Pickering emulsion with thymol as an antibacterial delivery system, Carbohydr. Polym., 200, 416, 10.1016\u002Fj.carbpol.2018.08.025\nKhan, 2020, Preparation and properties of High sheared Poly(Vinyl Alcohol)\u002FChitosan blended Hydrogels films with Lawsonia inermis extract as wound dressing, J. Drug Deliv. Sci. Technol., 102227\nMaver, 2015, Functional wound dressing materials with highly tunable drug release properties, RSC Adv., 5, 77873, 10.1039\u002FC5RA11972C\nQu, 2018, Antibacterial adhesive injectable hydrogels with rapid self-healing, extensibility and compressibility as wound dressing for joints skin wound healing, Biomaterials, 183, 185, 10.1016\u002Fj.biomaterials.2018.08.044\nKhan, 2020, Fabrication, physical characterizations, and in vitro, in vivo evaluation of ginger extract-loaded gelatin\u002Fpoly(vinyl alcohol) hydrogel films against burn wound healing in animal model, AAPS PharmSciTech, 21, 323, 10.1208\u002Fs12249-020-01866-y\nFan, 2017, Covalent and injectable chitosan-chondroitin sulfate hydrogels embedded with chitosan microspheres for drug delivery and tissue engineering, Mater. Sci. Eng. C, 71, 67, 10.1016\u002Fj.msec.2016.09.068\nGriffin, 2015, Accelerated wound healing by injectable microporous gel scaffolds assembled from annealed building blocks, Nat. Mater., 14, 737, 10.1038\u002Fnmat4294\nTran, 2011, In situ forming and rutin-releasing chitosan hydrogels as injectable dressings for dermal wound healing, Biomacromolecules, 12, 2872, 10.1021\u002Fbm200326g\nBalakrishnan, 2005, Evaluation of an in situ forming hydrogel wound dressing based on oxidized alginate and gelatin, Biomaterials, 26, 6335, 10.1016\u002Fj.biomaterials.2005.04.012\nDong, 2017, Injectable and tunable gelatin hydrogels enhance stem cell retention and improve cutaneous wound healing, Adv. Funct. Mater., 27, 1606619, 10.1002\u002Fadfm.201606619\nLoessner, 2016, Functionalization, preparation and use of cell-laden gelatin methacryloyl–based hydrogels as modular tissue culture platforms, Nat. Protoc., 11, 727, 10.1038\u002Fnprot.2016.037\nSun, 2020, Biological properties of sulfanilamide-loaded alginate hydrogel fibers based on ionic and chemical crosslinking for wound dressings, Int. J. Biol. Macromol., 157, 522, 10.1016\u002Fj.ijbiomac.2020.04.210\nChang, 2003, A genipin-crosslinked gelatin membrane as wound-dressing material: in vitro and in vivo studies, J. Biomater. Sci. Polym. Ed., 14, 481, 10.1163\u002F156856203766652084\nGull, 2020, Inflammation targeted chitosan-based hydrogel for controlled release of diclofenac sodium, Int. J. Biol. Macromol., 162, 175, 10.1016\u002Fj.ijbiomac.2020.06.133\nKristiansen, 2010, Periodate oxidation of polysaccharides for modification of chemical and physical properties, Carbohydr. Res., 345, 1264, 10.1016\u002Fj.carres.2010.02.011\nShumilina, 2002, Chitosan–carrageenan gels, Colloid J., 64, 372, 10.1023\u002FA:1015985229667\nDafe, 2017, Development of novel carboxymethyl cellulose\u002Fk-carrageenan blends as an enteric delivery vehicle for probiotic bacteria, Int. J. Biol. Macromol., 97, 299, 10.1016\u002Fj.ijbiomac.2017.01.016\nVarghese, 2014, Gelatin–carrageenan hydrogels: role of pore size distribution on drug delivery process, Colloids Surf. B Biointerfaces, 113, 346, 10.1016\u002Fj.colsurfb.2013.08.049\nGuo, 2014, Periodate oxidation of xanthan gum and its crosslinking effects on gelatin-based edible films, Food Hydrocolloids, 39, 243, 10.1016\u002Fj.foodhyd.2014.01.026\nDias, 2011, Oxidation of fermented cassava starch using hydrogen peroxide, Carbohydr. Polym., 86, 185, 10.1016\u002Fj.carbpol.2011.04.026\nWahid, 2019, Development of bacterial cellulose\u002Fchitosan based semi-interpenetrating hydrogels with improved mechanical and antibacterial properties, Int. J. Biol. Macromol., 122, 380, 10.1016\u002Fj.ijbiomac.2018.10.105\nNgwabebhoh, 2020, Self-crosslinked chitosan\u002Fdialdehyde xanthan gum blended hypromellose hydrogel for the controlled delivery of ampicillin, minocycline and rifampicin, Int. J. Biol. Macromol., 167, 1468, 10.1016\u002Fj.ijbiomac.2020.11.100\nHamedi, 2020, A novel double-network antibacterial hydrogel based on aminated bacterial cellulose and schizophyllan, Carbohydr. Polym., 229, 115383, 10.1016\u002Fj.carbpol.2019.115383\nNgwabebhoh, 2019, Nature‐derived fibrous nanomaterial toward biomedicine and environmental remediation: today's state and future prospects, J. Appl. Polym. Sci., 136, 47878, 10.1002\u002Fapp.47878\nLi, 2015, Bacterial cellulose–hyaluronan nanocomposite biomaterials as wound dressings for severe skin injury repair, J. Mater. Chem. B, 3, 3498, 10.1039\u002FC4TB01819B\nSulaeva, 2020, Fabrication of bacterial cellulose-based wound dressings with improved performance by impregnation with alginate, Mater. Sci. Eng. C, 110, 110619, 10.1016\u002Fj.msec.2019.110619\nSvensson, 2005, Bacterial cellulose as a potential scaffold for tissue engineering of cartilage, Biomaterials, 26, 419, 10.1016\u002Fj.biomaterials.2004.02.049\nYan, 2018, A novel and homogeneous scaffold material: preparation and evaluation of alginate\u002Fbacterial cellulose nanocrystals\u002Fcollagen composite hydrogel for tissue engineering, Polym. Bull., 75, 985, 10.1007\u002Fs00289-017-2077-0\nLi, 2020, All-natural injectable hydrogel with self-healing and antibacterial properties for wound dressing, Cellulose, 27, 2637, 10.1007\u002Fs10570-019-02942-8\nBandyopadhyay, 2018, Characterization of bacterial cellulose produced using media containing waste apple juice, Appl. Biochem. Microbiol., 54, 649, 10.1134\u002FS0003683818060042\nZhu, 2017, Preparation, characterization and antibacterial activity of oxidized kappa-carrageenan, Carbohydr. Polym., 174, 1051, 10.1016\u002Fj.carbpol.2017.07.029\nMuangman, 2011, Efficiency of microbial cellulose dressing in partial-thickness burn wounds, The Journal of the American College of Certified Wound Specialists, 3, 16, 10.1016\u002Fj.jcws.2011.04.001\nLu, 2019, Characterization, antimicrobial properties and coatings application of gellan gum oxidized with hydrogen peroxide, Foods, 8, 31, 10.3390\u002Ffoods8010031\nKumar, 2002, HNO3\u002FH3PO4–NANO2 mediated oxidation of cellulose — preparation and characterization of bioabsorbable oxidized celluloses in high yields and with different levels of oxidation, Carbohydr. Polym., 48, 403, 10.1016\u002FS0144-8617(01)00290-9\nGanji, 2007, Gelation time and degradation rate of chitosan-based injectable hydrogel, J. Sol. Gel Sci. Technol., 42, 47, 10.1007\u002Fs10971-006-9007-1\nGupta, 2006, Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord, Biomaterials, 27, 2370, 10.1016\u002Fj.biomaterials.2005.11.015\nErdagi, 2020, Genipin crosslinked gelatin-diosgenin-nanocellulose hydrogels for potential wound dressing and healing applications, Int. J. Biol. Macromol., 149, 651, 10.1016\u002Fj.ijbiomac.2020.01.279\nWang, 2005, Preparation of uniform sized chitosan microspheres by membrane emulsification technique and application as a carrier of protein drug, J. Contr. Release, 106, 62, 10.1016\u002Fj.jconrel.2005.04.005\nSiepmann, 2012, Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC), Adv. Drug Deliv. Rev., 64, 163, 10.1016\u002Fj.addr.2012.09.028\nRen, 2017, Injectable hydrogel based on quaternized chitosan, gelatin and dopamine as localized drug delivery system to treat Parkinson's disease, Int. J. Biol. Macromol., 105, 1079, 10.1016\u002Fj.ijbiomac.2017.07.130\nKorsmeyer, 1983, Mechanisms of solute release from porous hydrophilic polymers, Int. J. Pharm., 15, 25, 10.1016\u002F0378-5173(83)90064-9\nGao, 2013, In vitro release kinetics of antituberculosis drugs from nanoparticles assessed using a modified dissolution apparatus, BioMed Res. Int., 2013, 10.1155\u002F2013\u002F136590\nMa, 2018, Injectable hydrogels based on the hyaluronic acid and poly (γ-glutamic acid) for controlled protein delivery, Carbohydr. Polym., 179, 100, 10.1016\u002Fj.carbpol.2017.09.071\nPooresmaeil, 2020, Facile preparation of pH-sensitive chitosan microspheres for delivery of curcumin; characterization, drug release kinetics and evaluation of anticancer activity, Int. J. Biol. Macromol., 162, 501, 10.1016\u002Fj.ijbiomac.2020.06.183\nZhou, 2016, Oxidized amylose with high carboxyl content: a promising solubilizer and carrier of linalool for antimicrobial activity, Carbohydr. Polym., 154, 13, 10.1016\u002Fj.carbpol.2016.08.030\nPietrzyk, 2012, The influence of Cu (II) ions on physicochemical properties of potato starch oxidised by hydrogen peroxide, Starch Staerke, 64, 272, 10.1002\u002Fstar.201100090\nZhang, 2019, Pullulan dialdehyde crosslinked gelatin hydrogels with high strength for biomedical applications, Carbohydr. Polym., 216, 45, 10.1016\u002Fj.carbpol.2019.04.004\nAnnabi, 2011, The effect of elastin on chondrocyte adhesion and proliferation on poly (ϵ-caprolactone)\u002Felastin composites, Biomaterials, 32, 1517, 10.1016\u002Fj.biomaterials.2010.10.024\nTang, 2020, Rheological and structural properties of sodium caseinate as influenced by locust bean gum and κ-carrageenan, Food Hydrocolloids, 106251\nPaximada, 2016, Effect of bacterial cellulose addition on physical properties of WPI emulsions. Comparison with common thickeners, Food Hydrocolloids, 54, 245, 10.1016\u002Fj.foodhyd.2015.10.014\nYegappan, 2018, Carrageenan based hydrogels for drug delivery, tissue engineering and wound healing, Carbohydr. Polym., 198, 385, 10.1016\u002Fj.carbpol.2018.06.086\nGu, 2019, Preparation and characterization of methacrylated gelatin\u002Fbacterial cellulose composite hydrogels for cartilage tissue engineering, Regenerative Biomaterials, 7, 195, 10.1093\u002Frb\u002Frbz050\nYu, 2010, The preparation and properties of dialdehyde starch and thermoplastic dialdehyde starch, Carbohydr. Polym., 79, 296, 10.1016\u002Fj.carbpol.2009.08.005\nYe, 2019, Development of gelatin\u002Fbacterial cellulose composite sponges as potential natural wound dressings, Int. J. Biol. Macromol., 133, 148, 10.1016\u002Fj.ijbiomac.2019.04.095\nTahtat, 2013, Oral delivery of insulin from alginate\u002Fchitosan crosslinked by glutaraldehyde, Int. J. Biol. Macromol., 58, 160, 10.1016\u002Fj.ijbiomac.2013.03.064\nKhamrai, 2017, Modified bacterial cellulose based self-healable polyeloctrolyte film for wound dressing application, Carbohydr. Polym., 174, 580, 10.1016\u002Fj.carbpol.2017.06.094\nPeña, 2010, Enhancing water repellence and mechanical properties of gelatin films by tannin addition, Bioresour. Technol., 101, 6836, 10.1016\u002Fj.biortech.2010.03.112\nBigi, 2004, Relationship between triple-helix content and mechanical properties of gelatin films, Biomaterials, 25, 5675, 10.1016\u002Fj.biomaterials.2004.01.033\nAsma, 2014, Physicochemical characterization of gelatin-cmc composite edibles films from polyion-complex hydrogels, J. Chil. Chem. Soc., 59, 2279, 10.4067\u002FS0717-97072014000100008\nTaokaew, 2013, Biosynthesis and characterization of nanocellulose-gelatin films, Materials, 6, 782, 10.3390\u002Fma6030782\nTreesuppharat, 2017, Synthesis and characterization of bacterial cellulose and gelatin-based hydrogel composites for drug-delivery systems, Biotechnology Reports, 15, 84, 10.1016\u002Fj.btre.2017.07.002\nKiortsis, 2005, Drug release from tableted wet granulations comprising cellulosic (HPMC or HPC) and hydrophobic component, Eur. J. Pharm. Biopharm., 59, 73, 10.1016\u002Fj.ejpb.2004.05.004\nda Silva, 2012, Modelling natamycin release from alginate\u002Fchitosan active films, International Journal of Food Science, 47, 740, 10.1111\u002Fj.1365-2621.2011.02902.x\nChang, 2016, Physical properties of bacterial cellulose composites for wound dressings, Food Hydrocolloids, 53, 75, 10.1016\u002Fj.foodhyd.2014.12.009\nWang, 2012, 194",{"EN":796},"Preparation and characterization of injectable self-antibacterial gelatin\u002Fcarrageenan\u002Fbacterial cellulose hydrogel scaffolds for wound healing application",{"VOID":798},"10.1016\u002Fj.jddst.2021.102415","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1773224721000952",[801,826,855,874,893],{"id":802,"sortIndex":154,"researcher":18,"roles":803,"affiliations":804,"properties":823},"e2ddfcf1-8748-4c84-b851-175f892dd822",[117],[805,815],{"id":806,"sortIndex":115,"affiliation":807,"properties":814},"f2910435-29d8-4d7d-856c-a9bffe883025",{"id":808,"createTime":809,"updateTime":809,"relativeEntities":810,"slug":18,"properties":811,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"8af74d05-b6f7-428c-b37c-2b1aa2dcef5e","2023-11-30T00:02:20.580+00:00",[],{"title":812},{"VI":813},"Footwear Research Centre, University Institute, Tomas Bata University in Zlin, Nad Ovcirnou IV, 3685 Zlin, Czech Republic",{},{"id":18,"sortIndex":19,"affiliation":816,"properties":18},{"id":817,"createTime":818,"updateTime":818,"relativeEntities":819,"slug":18,"properties":820,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"a8910dac-a1a7-4a05-a16a-1988dc29f4d9","2024-01-15T00:23:21.593+00:00",[],{"title":821},{"VI":822},"Centre of Polymer Systems, University Institute, Tomas Bata University in Zlin, Tr. T. Bati 5678, 76001 Zlin, Czech Republic",{"title":824},{"VI":825},"Oyunchimeg Zandraa",{"id":827,"sortIndex":245,"researcher":18,"roles":828,"affiliations":829,"properties":852},"e5f487fb-864a-4b70-a09a-64568a5f612c",[117],[830,840,847],{"id":831,"sortIndex":154,"affiliation":832,"properties":839},"77b87b4a-e31f-4acd-84eb-1d777e4a46ee",{"id":833,"createTime":834,"updateTime":834,"relativeEntities":835,"slug":18,"properties":836,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"9df428db-1b06-42fa-9b1f-052f9894069a","2023-12-02T11:51:58.429+00:00",[],{"title":837},{"VI":838},"Faculty of Technology, Tomas Bata University in Zlin, Vavrečkova 275, 76001, Zlin, Czech Republic",{},{"id":841,"sortIndex":115,"affiliation":842,"properties":846},"b917f4b2-3a08-455a-b5a6-163dcaab3439",{"id":808,"createTime":809,"updateTime":809,"relativeEntities":843,"slug":18,"properties":844,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":845},{"VI":813},{},{"id":18,"sortIndex":19,"affiliation":848,"properties":18},{"id":817,"createTime":818,"updateTime":818,"relativeEntities":849,"slug":18,"properties":850,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":851},{"VI":822},{"title":853},{"VI":854},"Petr Saha",{"id":856,"sortIndex":19,"researcher":18,"roles":857,"affiliations":858,"properties":871},"35f4567a-cd45-4cd5-812b-9e800eb4e816",[117],[859,866],{"id":860,"sortIndex":115,"affiliation":861,"properties":865},"b1635961-feed-40c9-b083-69f33bac99e8",{"id":808,"createTime":809,"updateTime":809,"relativeEntities":862,"slug":18,"properties":863,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":864},{"VI":813},{},{"id":18,"sortIndex":19,"affiliation":867,"properties":18},{"id":817,"createTime":818,"updateTime":818,"relativeEntities":868,"slug":18,"properties":869,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":870},{"VI":822},{"title":872},{"VI":873},"Fahanwi Asabuwa Ngwabebhoh",{"id":875,"sortIndex":115,"researcher":18,"roles":876,"affiliations":877,"properties":890},"c0f2c4c1-0e5a-4ac9-b7c2-cebc6b77ad03",[117],[878,885],{"id":879,"sortIndex":115,"affiliation":880,"properties":884},"7c0676c3-9470-4ea7-9020-ef8dd8c848a7",{"id":808,"createTime":809,"updateTime":809,"relativeEntities":881,"slug":18,"properties":882,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":883},{"VI":813},{},{"id":18,"sortIndex":19,"affiliation":886,"properties":18},{"id":817,"createTime":818,"updateTime":818,"relativeEntities":887,"slug":18,"properties":888,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":889},{"VI":822},{"title":891},{"VI":892},"Rahul Patwa",{"id":894,"sortIndex":214,"researcher":18,"roles":895,"affiliations":896,"properties":916},"c3aa1a41-3ec1-4bb9-8050-dba146b157e5",[117],[897,904,909],{"id":898,"sortIndex":115,"affiliation":899,"properties":903},"fb77dbaa-0b18-4210-98ca-3e5dacc8b77b",{"id":808,"createTime":809,"updateTime":809,"relativeEntities":900,"slug":18,"properties":901,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":902},{"VI":813},{},{"id":18,"sortIndex":19,"affiliation":905,"properties":18},{"id":817,"createTime":818,"updateTime":818,"relativeEntities":906,"slug":18,"properties":907,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":908},{"VI":822},{"id":910,"sortIndex":154,"affiliation":911,"properties":915},"70efd622-cc4d-4717-b3f4-6b66a68ea183",{"id":833,"createTime":834,"updateTime":834,"relativeEntities":912,"slug":18,"properties":913,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":914},{"VI":838},{},{"title":917},{"VI":918},"Nabanita Saha",{"url":799,"publisher":920,"properties":942},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":921,"slug":10,"properties":922,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":925,"manageAffiliations":926,"indexDatabases":927,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":923,"title":924},{"VOID":13},{"EN":15},[],[],[928,935],{"id":73,"indexDatabase":929,"url":86,"indexYears":87,"academicFieldIds":934,"indexDatabaseRanking":90},{"id":75,"createTime":76,"updateTime":77,"relativeEntities":930,"label":931,"description":932,"key":83,"publicationTags":933,"standard":18},[],{"EN":80,"VI":80},{"EN":80,"VI":82},[85],[89],{"id":54,"indexDatabase":936,"url":69,"indexYears":18,"academicFieldIds":941,"indexDatabaseRanking":18},{"id":56,"createTime":57,"updateTime":58,"relativeEntities":937,"label":938,"description":939,"key":65,"publicationTags":940,"standard":18},[],{"EN":61,"VI":61},{"VI":63,"EN":64},[67,68],[71],{"volume":943,"pages":945},{"VOID":944},"63",{"VOID":946},"102415","2021-06-01",2021,{"id":950,"createTime":951,"updateTime":952,"relativeEntities":953,"slug":954,"properties":955,"entityType":108,"verifyStatus":109,"verifyTime":962,"verifyNote":110,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":963,"fullTextUrl":18,"authors":964,"publicationType":165,"publisherRelationship":992,"citationCount":18,"citationInfo":18,"publishDate":1020,"publishYear":408,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":196},"7a39b9bc-1877-4d05-93bf-4e7a0682b18c","2024-01-08T09:40:49.554+00:00","2025-01-01T23:53:19.079+00:00",[],"Laser-empowered-chemo-free-phytotherapy-Newer-approach-in-anticancer-therapeutics-delivery",{"references":956,"title":958,"doi":960},{"VOID":957},"Cox, 2021, The matrix in cancer, Nat. Rev. Cancer, 21, 217, 10.1038\u002Fs41568-020-00329-7\nZhang, 2021, Alternative splicing and cancer: a systematic review, Signal Transduct. Targeted Ther., 6, 1\nKreissl, 2019, Current treatment strategies in metastasized differentiated thyroid cancer, J. Nucl. Med., 60, 9, 10.2967\u002Fjnumed.117.190819\nXie, 2021, The metastasizing mechanisms of lung cancer: recent advances and therapeutic challenges, Biomed. Pharmacother., 138, 10.1016\u002Fj.biopha.2021.111450\nFerlay, 2021, Cancer statistics for the year 2020: an overview, Int. J. Cancer, 149, 778, 10.1002\u002Fijc.33588\nSiegel, 2021, Cancer statistics, 2021, CA A Cancer J. Clin., 71, 7, 10.3322\u002Fcaac.21654\nEloranta, 2021, Cancer survival statistics for patients and healthcare professionals–a tutorial of real‐world data analysis, J. Intern. Med., 289, 12, 10.1111\u002Fjoim.13139\nSung, 2021, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA A Cancer J. Clin., 71, 209, 10.3322\u002Fcaac.21660\nSoerjomataram, 2021, Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070, Nat. Rev. Clin. Oncol., 18, 663, 10.1038\u002Fs41571-021-00514-z\nBray, 2021, The ever‐increasing importance of cancer as a leading cause of premature death worldwide, Cancer, 127, 3029, 10.1002\u002Fcncr.33587\nElmore, 2021, Blueprint for cancer research: critical gaps and opportunities, CA Cancer, J. Clin., 71, 107\nYousefi, 2021, Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistance, Oncogene, 40, 1043, 10.1038\u002Fs41388-020-01588-2\nVan den Ackerveken, 2021, A novel proteomics approach to epigenetic profiling of circulating nucleosomes, Sci. Rep., 11, 1, 10.1038\u002Fs41598-021-86630-3\nLarson, 2021, A comprehensive characterization of the cell-free transcriptome reveals tissue-and subtype-specific biomarkers for cancer detection, Nat. Commun., 12, 1, 10.1038\u002Fs41467-021-22444-1\nAsnani, 2021, Preclinical models of cancer therapy–associated cardiovascular toxicity: a scientific statement from the American heart association, Circ. Res., 129, e21, 10.1161\u002FRES.0000000000000473\nHerrmann, 2022, Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement, Eur. Heart J., 43, 280, 10.1093\u002Feurheartj\u002Fehab674\nCintrón-García, 2020, Management of CNS toxicity of chemotherapy and targeted agents: 2020, Am. J. Cancer Res., 10, 2617\nH. Majeed, V. Gupta, Adverse Effects of Radiation Therapy, StatPearls [Internet], StatPearls Publishing2021.\nTimmerman, 2018, Long-term results of stereotactic body radiation therapy in medically inoperable stage I non–small cell lung cancer, JAMA Oncol., 4, 1287, 10.1001\u002Fjamaoncol.2018.1258\nThompson, 2018, Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie?, Br. J. Cancer, 119, 389, 10.1038\u002Fs41416-018-0201-z\nHoy, 2019, Surgical treatment of lung cancer, Crit. Care Nur. Clin., 31, 303, 10.1016\u002Fj.cnc.2019.05.002\nSchmidt, 2019, Return to work after breast cancer: the role of treatment‐related side effects and potential impact on quality of life, Eur. J. Cancer Care, 28, 10.1111\u002Fecc.13051\nCaufriez, 2020, Peptide-based targeting of connexins and pannexins for therapeutic purposes, Expet Opin. Drug Discov., 15, 1213, 10.1080\u002F17460441.2020.1773787\nGuo, 2021, Mito‐bomb: targeting mitochondria for cancer therapy, Adv. Mater., 33\nMa, 2021, Plant natural products: promising resources for cancer chemoprevention, Molecules, 26, 933, 10.3390\u002Fmolecules26040933\nPezzani, 2019, Synergistic effects of plant derivatives and conventional chemotherapeutic agents: an update on the cancer perspective, Medicina, 55, 110, 10.3390\u002Fmedicina55040110\nLin, 2020, Natural compounds as potential adjuvants to cancer therapy: preclinical evidence, Br. J. Pharmacol., 177, 1409, 10.1111\u002Fbph.14816\nMore, 2021, Pharmacognosy, phytochemistry, pharmacology and clinical application of Ginkgo biloba, GSC Biol. Pharm. Sci., 16, 229, 10.30574\u002Fgscbps.2021.16.2.0249\nRather, 2020, Quercetin as an innovative therapeutic tool for cancer chemoprevention: molecular mechanisms and implications in human health, Cancer Med., 9, 9181, 10.1002\u002Fcam4.1411\nTang, 2020, Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects, Biomed. Pharmacother., 121, 10.1016\u002Fj.biopha.2019.109604\nBoojar, 2020, Overview of Silibinin anti-tumor effects, J. Herb. Med., 23\nFallah, 2021, Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer, Biomed. Pharmacother., 142, 10.1016\u002Fj.biopha.2021.112024\nDou, 2018, Baicalein and baicalin inhibit colon cancer using two distinct fashions of apoptosis and senescence, Oncotarget, 9, 10.18632\u002Foncotarget.24015\nSingh, 2021, Baicalin mediated regulation of key signaling pathways in cancer, Pharmacol. Res., 164, 10.1016\u002Fj.phrs.2020.105387\nLi, 2017, Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?, Am. J. Cancer Res., 7, 2350\nMohamed, 2020, Galenia africana plant extract exhibits cytotoxicity in breast cancer cells by inducing multiple programmed cell death pathways, Saudi Pharmaceut. J., 28, 1155, 10.1016\u002Fj.jsps.2020.08.004\nBitting, 2021, Phase I study of muscadine grape extract for patients with advanced cancer, Am. J. Clin. Oncol., 44, 239, 10.1097\u002FCOC.0000000000000814\nSahoo, 2020, In vitro anticancer activity of Eclipta alba whole plant extract on colon cancer cell HCT-116, BMC complement. med. ther., 20, 1\nLang, 2019, Antitumor activity of an Artemisia annua herbal preparation and identification of active ingredients, Phytomedicine, 62, 10.1016\u002Fj.phymed.2019.152962\nDell'Olmo, 2021, Fighting multidrug resistance with a fruit extract: anti-cancer and anti-biofilm activities of Acca sellowiana, Nat. Prod. Res., 35, 1686, 10.1080\u002F14786419.2019.1624961\nIsmail, 2021, Christia vespertilionis extract induced antiproliferation and apoptosis in breast cancer (MCF7) cells, Mol. Biol. Rep., 48, 7361, 10.1007\u002Fs11033-021-06743-w\nKwon, 2021, Alisma canaliculatum extract affects AGS gastric cancer cells by inducing apoptosis, Int. J. Med. Sci., 18, 2155, 10.7150\u002Fijms.55212\nKhodavirdipour, 2021, Evaluation of the anti-cancer effect of Syzygium cumini ethanolic extract on HT-29 colorectal cell line, J. Gastrointest. Cancer, 52, 575, 10.1007\u002Fs12029-020-00439-3\nSimonovic, 2021, Raspberry seeds extract selectively inhibits the growth of human lung cancer cells in vitro, Nat. Prod. Res., 35, 2253, 10.1080\u002F14786419.2019.1666391\nNedungadi, 2021, Ginger extract activates caspase independent paraptosis in cancer cells via ER stress, mitochondrial dysfunction, AIF trans. DNA damage Nutr. Cancer, 73, 147\nSudha, 2021, Pomegranate (Punica granatum) Fruit extract suppresses cancer progression and tumor angiogenesis of pancreatic and colon cancer in chick Chorioallantoic membrane model, Nutr. Cancer, 73, 1350, 10.1080\u002F01635581.2020.1800768\nAli, 2021, The anticancer properties of Artemisia aucheri boiss extract on HT29 colon cancer cells, J. Gastrointest. Cancer, 52, 113, 10.1007\u002Fs12029-019-00354-2\nMarquez, 2020, Alangium longiflorum Merr. leaf extract induces apoptosis in A549 lung cancer cells with minimal NFκB transcriptional activation, Asian Pac. J. Cancer Prev. APJCP, 21, 2453, 10.31557\u002FAPJCP.2020.21.8.2453\nKe, 2021, Foeniculum vulgare seed extract induces apoptosis in lung cancer cells partly through the down-regulation of Bcl-2, Biomed, Pharma, 135\nMesas, 2021, Antitumor effect of the ethanolic extract from seeds of Euphorbia lathyris in colorectal cancer, Nutrients, 13, 566, 10.3390\u002Fnu13020566\nYang, 2021, Ruyiping extract reduces lung metastasis in triple negative breast cancer by regulating macrophage polarization, Biomed. Pharmacother., 141, 10.1016\u002Fj.biopha.2021.111883\nAbeesh, 2021, Edible sword bean extract induces apoptosis in cancer cells in vitro and inhibits ascites and solid tumor development in vivo, Nutr. Cancer, 73, 1015, 10.1080\u002F01635581.2020.1781202\nNguyen, 2019, Hibiscus flower extract selectively induces apoptosis in breast cancer cells and positively interacts with common chemotherapeutics, BMC Compl. Alternative Med., 19, 1\nPandey, 2021, Jab1 inhibition by methanolic extract of Moringa oleifera leaves in cervical cancer cells: a potent targeted therapeutic approach, Nutr. Cancer, 73, 2411, 10.1080\u002F01635581.2020.1826989\nHuang, 2020, Extract of Juniperus indica Bertol synergizes with cisplatin to inhibit oral cancer cell growth via repression of cell cycle progression and activation of the caspase cascade, Molecules, 25, 2746, 10.3390\u002Fmolecules25122746\nAkhouri, 2020, Therapeutic effect of Aegle marmelos fruit extract against DMBA induced breast cancer in rats, Sci. Rep., 10, 1, 10.1038\u002Fs41598-020-72935-2\nYurasakpong, 2021, Holothuria scabra extract induces cell apoptosis and suppresses Warburg effect by down-regulating Akt\u002FmTOR\u002FHIF-1 axis in MDA-MB-231 breast cancer cells, Nutr. Cancer, 73, 1964, 10.1080\u002F01635581.2020.1814825\nSoumya, 2021, Anticancer potential of rhizome extract and a labdane diterpenoid from Curcuma mutabilis plant endemic to Western Ghats of India, Sci. Rep., 11, 1, 10.1038\u002Fs41598-020-79414-8\nGnocchi, 2021, Treatment of liver cancer cells with ethyl acetate extract of Crithmum maritimum permits reducing sorafenib dose and toxicity maintaining its efficacy, J. Pharm. Pharmacol., 73, 1369, 10.1093\u002Fjpp\u002Frgab070\nColamba Pathiranage, 2021, Hexane extract of Garcinia quaesita fruits induces apoptosis in breast cancer stem cells isolated from triple negative breast cancer cell line MDA-MB-231, Nutr. Cancer, 73, 845, 10.1080\u002F01635581.2020.1773511\nKusmardi, 2021\nLee, 2021, Artemisia kruhsiana leaf extract induces autophagic cell death in human prostate cancer cells, Chin. J. Nat. Med., 19, 134\nSiddiqui, 2021, Antiproliferative activity of Cissus quadrangularis L. extract against human cervical cancer cells: in vitro and in silico analysis, Anti-Cancer Agents in Medicinal Chemistry, Form. Curr. Med. Chem.-Anti-Cancer Agents), 21, 2536, 10.2174\u002F1871520621666210210103729\nWinitchaikul, 2021, Calotropis gigantea stem bark extract induced apoptosis related to ROS and ATP production in colon cancer cells, PLoS One, 16, 10.1371\u002Fjournal.pone.0254392\nShu, 2021, Tribulus terrestris fruit extract inhibits autophagic flux to diminish cell proliferation and metastatic characteristics of oral cancer cells, Environ. Toxicol., 36, 1173, 10.1002\u002Ftox.23116\nSandhir, 2015, Nano-antioxidants: an emerging strategy for intervention against neurodegenerative conditions, Neurochem. Int., 89, 209, 10.1016\u002Fj.neuint.2015.08.011\nChen, 2019, Catalase-like metal–organic framework nanoparticles to enhance radiotherapy in hypoxic cancer and prevent cancer recurrence, Chem. Sci., 10, 5773, 10.1039\u002FC9SC00747D\nZhen, 2018, BSA‐IrO2: catalase‐like nanoparticles with high photothermal conversion efficiency and a high x‐ray absorption coefficient for anti‐inflammation and antitumor theranostics, Angew. Chem., 130, 10466, 10.1002\u002Fange.201804466\nKepinska, 2018, Metallothionein and superoxide dismutase—antioxidative protein status in fullerene-doxorubicin delivery to MCF-7 human breast cancer cells, Int. J. Mol. Sci., 19, 3253, 10.3390\u002Fijms19103253\nCho, 2019, Tumor homing reactive oxygen species nanoparticle for enhanced cancer therapy, ACS Appl. Mater. Interfaces, 11, 23909, 10.1021\u002Facsami.9b07483\nBarani, 2021, Phytosomes as innovative delivery systems for phytochemicals: a comprehensive review of literature, Int. J. Nanomed., 16, 6983, 10.2147\u002FIJN.S318416\nKudatarkar, 2022, Analytical method development and validation for estimation of chrysin in chrysin loaded phytosomes using high performance thin layer chromatography, J. Liq. Chromatogr. Relat. Technol., 1\nAl-Rabia, 2022, Boosting curcumin activity against human prostatic cancer PC3 cells by utilizing scorpion venom conjugated phytosomes as promising functionalized nanovesicles, Drug Deliv., 29, 807, 10.1080\u002F10717544.2022.2048133\nAmiri, 2021, Plant-based gums and mucilages applications in pharmacology and nanomedicine: a review, Molecules, 26, 1770, 10.3390\u002Fmolecules26061770\nLai, 2020, Ionically crosslinked complex gels loaded with oleic acid-containing vesicles for transdermal drug delivery, Pharmaceutics, 12, 725, 10.3390\u002Fpharmaceutics12080725\nLai, 2021, A self-indicating cellulose-based gel with tunable performance for bioactive agent delivery, J. Drug Deliv. Sci. Technol., 63\nMaheshwari, 2015, Chitosan encrusted nonionic surfactant based vesicular formulation for topical administration of ofloxacin, Sci. Adv. Mater., 7, 1163, 10.1166\u002Fsam.2015.2245\nMaheshwari, 2022, Laser activatable nanographene colloids for chemo-photothermal combined gene therapy of triple-negative breast cancer, Biomaterials Advances, 133, 10.1016\u002Fj.msec.2021.112605\nLi, 2021, Core-shell chitosan microsphere with antimicrobial and vascularized functions for promoting skin wound healing, Mater. Des., 204, 10.1016\u002Fj.matdes.2021.109683\nSainy, 2020\nR. Maheshwari, K.N. Kuche, A. Advankar, N. Soni, N. Raval, P.A. Sharma, M. Tekade, R.K. Tekade, Natural Ingredients\u002FBotanical Extracts for the Nutraceutical Industry, Flavors for Nutraceutical and Functional Foods, CRC Press2018, pp. 75-122.\nJogi, 2018, Carbon nanotubes in the delivery of anticancer herbal drugs, Nanomedicine, 13, 1187, 10.2217\u002Fnnm-2017-0397\nM. Tekade, N. Maheshwari, S.R. Youngren-Ortiz, V. Pandey, Y. Chourasiya, V. Soni, P.K. Deb, M.C. Sharma, Thiolated-chitosan: A Novel Mucoadhesive Polymer for Better-Targeted Drug Delivery, Biomaterials and Bionanotechnology, Elsevier2019, pp. 459-493.\nShi, 2020, How promising is phototherapy for cancer?, Br. J. Cancer, 123, 871, 10.1038\u002Fs41416-020-0926-3\nZhi, 2020, Photothermal therapy, J. Contr. Release, 325, 52, 10.1016\u002Fj.jconrel.2020.06.032\nJung, 2018, Organic molecule-based photothermal agents: an expanding photothermal therapy universe, Chem. Soc. Rev., 47, 2280, 10.1039\u002FC7CS00522A\nXu, 2020, Near infrared light triggered photo\u002Fimmuno-therapy toward cancers, Front. Bioeng. Biotechnol., 8, 488, 10.3389\u002Ffbioe.2020.00488\nTang, 2021, NIR light-responsive nanocarriers for controlled release, J. Photochem. Photobiol. C Photochem. Rev., 47, 10.1016\u002Fj.jphotochemrev.2021.100420\nZhang, 2021, Light-responsive nanomaterials for cancer therapy, Engineering, 13, 18, 10.1016\u002Fj.eng.2021.07.023\nHan, 2021, Advances in nanomaterial-mediated photothermal cancer therapies: toward clinical applications, Biomedicines, 9, 305, 10.3390\u002Fbiomedicines9030305\nSun, 2021, Near-infrared photoactivated nanomedicines for photothermal synergistic cancer therapy, Nano Today, 37, 10.1016\u002Fj.nantod.2020.101073\nYang, 2018, Black phosphorus nanosheets immobilizing Ce6 for imaging-guided photothermal\u002Fphotodynamic cancer therapy, ACS Appl. Mater. Interfaces, 10, 12431, 10.1021\u002Facsami.8b00276\nZhou, 2021, Construction of smart nanotheranostic platform Bi-Ag@ PVP: multimodal CT\u002FPA imaging-guided PDT\u002FPTT for cancer therapy, ACS Omega, 6, 10723, 10.1021\u002Facsomega.1c00225\nHussein, 2018, Recent advances in functional nanostructures as cancer photothermal therapy, Int. J. Nanomed., 13, 2897, 10.2147\u002FIJN.S161031\nSinghai, 2020, Chondroitin sulphate and α-tocopheryl succinate tethered multiwalled carbon nanotubes for dual-action therapy of triple-negative breast cancer, J. Drug Deliv. Sci. Technol., 60\nSinghai, 2020, CD44 receptor targeted ‘smart’multi-walled carbon nanotubes for synergistic therapy of triple-negative breast cancer, Colloid and Interf. Sci. Commun., 35, 10.1016\u002Fj.colcom.2020.100235\nMonaco, 2021, Quickly evolving near-infrared photoimmunotherapy provides multifaceted approach to modern cancer treatment, View\nWang, 2020, In-vitro photothermal therapy using plant extract polyphenols functionalized graphene sheets for treatment of lung cancer, J. Photochem. Photobiol. B Biol., 204, 10.1016\u002Fj.jphotobiol.2019.111587\nYang, 2010, Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy, Nano Lett., 10, 3318, 10.1021\u002Fnl100996u\nFazal, 2014, Green synthesis of anisotropic gold nanoparticles for photothermal therapy of cancer, ACS Appl. Mater. Interfaces, 6, 8080, 10.1021\u002Fam500302t\nPemmaraju, 2018, Chlorophyll rich biomolecular fraction of A. cadamba loaded into polymeric nanosystem coupled with Photothermal Therapy: a synergistic approach for cancer theranostics, Int. J. Biol. Macromol., 110, 383, 10.1016\u002Fj.ijbiomac.2017.09.084\nFoo, 2019, Green synthesised-gold nanoparticles in photothermal therapy of breast cancer, Micro & Nano Lett., 14, 470, 10.1049\u002Fmnl.2018.5557\nMa, 2019, Grape seed-inspired smart hydrogel scaffolds for melanoma therapy and wound healing, ACS Nano, 13, 4302, 10.1021\u002Facsnano.8b09496\nJiang, 2019, Green tea extract-assembled nanoclusters for combinational photothermal and chemotherapy, J. Mater. Chem. B, 7, 5972, 10.1039\u002FC9TB01546A\nMeena, 2019, Fluorescent carbon dots driven from ayurvedic medicinal plants for cancer cell imaging and phototherapy, Heliyon, 5, 10.1016\u002Fj.heliyon.2019.e02483\nTeng, 2020, Extract derived from black rice functions as a photothermal agent for suppressing tumor growth and metastasis, Front. Bioeng. Biotechnol., 904, 10.3389\u002Ffbioe.2020.00904\nYang, 2021, Green synthesis of reduced graphene oxide (RGO) using the plant extract of Salvia spinosa and evaluation of photothermal effect on pancreatic cancer cells, J. Mol. Struct., 1245, 10.1016\u002Fj.molstruc.2021.131064\nYang, 2021, Natural pollen extract for photothermal therapy, Mater. Des., 202, 10.1016\u002Fj.matdes.2021.109573\nVo, 2021, Rice starch coated iron oxide nanoparticles: a theranostic probe for photoacoustic imaging-guided photothermal cancer therapy, Int. J. Biol. Macromol., 183, 55, 10.1016\u002Fj.ijbiomac.2021.04.053\nBaghbani-Arani, 2017, Photo-catalytic, anti-bacterial, and anti-cancer properties of phyto-mediated synthesis of silver nanoparticles from Artemisia tournefortiana Rchb extract, J. Photochem. Photobiol. B Biol., 173, 640, 10.1016\u002Fj.jphotobiol.2017.07.003\nSumitha, 2018, Phyto-mediated photo catalysed green synthesis of silver nanoparticles using Durio zibethinus seed extract: antimicrobial and cytotoxic activity and photocatalytic applications, Molecules, 23, 3311, 10.3390\u002Fmolecules23123311\nHuang, 2021, Poly-tannic acid coated paclitaxel nanocrystals for combinational photothermal-chemotherapy, Colloids Surf. B Biointerfaces, 197, 10.1016\u002Fj.colsurfb.2020.111377",{"EN":959},"Laser empowered ‘chemo-free’ phytotherapy: Newer approach in anticancer therapeutics delivery",{"VOID":961},"10.1016\u002Fj.jddst.2022.103709","2025-01-01T23:53:19.078+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1773224722006207",[965,980],{"id":966,"sortIndex":19,"researcher":18,"roles":967,"affiliations":968,"properties":977},"ef47d112-3e94-40cc-bc49-0f079b122414",[117],[969],{"id":18,"sortIndex":19,"affiliation":970,"properties":18},{"id":971,"createTime":972,"updateTime":972,"relativeEntities":973,"slug":18,"properties":974,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"95cbe59a-1cfc-42a6-9b1d-344ed41e381e","2024-01-08T09:40:49.564+00:00",[],{"title":975},{"VI":976},"School of Pharmacy, Devi Ahilya Vishwavidyalaya, Takshila Campus, Indore, 452001, MP, India",{"title":978},{"VI":979},"Neha Maheshwari",{"id":981,"sortIndex":115,"researcher":18,"roles":982,"affiliations":983,"properties":989},"14a16e62-94bd-4068-919a-5f33101b2b28",[117],[984],{"id":18,"sortIndex":19,"affiliation":985,"properties":18},{"id":971,"createTime":972,"updateTime":972,"relativeEntities":986,"slug":18,"properties":987,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":988},{"VI":976},{"title":990},{"VI":991},"Mukesh C. Sharma",{"url":963,"publisher":993,"properties":1015},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":994,"slug":10,"properties":995,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":998,"manageAffiliations":999,"indexDatabases":1000,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":996,"title":997},{"VOID":13},{"EN":15},[],[],[1001,1008],{"id":73,"indexDatabase":1002,"url":86,"indexYears":87,"academicFieldIds":1007,"indexDatabaseRanking":90},{"id":75,"createTime":76,"updateTime":77,"relativeEntities":1003,"label":1004,"description":1005,"key":83,"publicationTags":1006,"standard":18},[],{"EN":80,"VI":80},{"EN":80,"VI":82},[85],[89],{"id":54,"indexDatabase":1009,"url":69,"indexYears":18,"academicFieldIds":1014,"indexDatabaseRanking":18},{"id":56,"createTime":57,"updateTime":58,"relativeEntities":1010,"label":1011,"description":1012,"key":65,"publicationTags":1013,"standard":18},[],{"EN":61,"VI":61},{"VI":63,"EN":64},[67,68],[71],{"volume":1016,"pages":1018},{"VOID":1017},"75",{"VOID":1019},"103709","2022-09-01",{"id":1022,"createTime":1023,"updateTime":1024,"relativeEntities":1025,"slug":1026,"properties":1027,"entityType":108,"verifyStatus":109,"verifyTime":1024,"verifyNote":110,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":1034,"fullTextUrl":18,"authors":1035,"publicationType":165,"publisherRelationship":1105,"citationCount":18,"citationInfo":18,"publishDate":1133,"publishYear":1134,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":196},"b39a0b5a-39b0-4ec5-98a6-0be6663798f7","2023-12-25T21:06:08.075+00:00","2025-01-09T23:52:51.890+00:00",[],"Development-of-drug-reservoirs-based-on-nanofibers-and-capsules-for-epistaxis-treatment",{"references":1028,"title":1030,"doi":1032},{"VOID":1029},"Krulewitz, 2019, Epistaxis, Emerg. Med. Clin. N. Am., 37, 29, 10.1016\u002Fj.emc.2018.09.005\nMacoto, 2018, Breaking paradigms in severe epistaxis: the importance of looking for the S-point, Braz. J. Otorhinolaryngol., 84, 290, 10.1016\u002Fj.bjorl.2017.12.007\nCamacho, 2018, Risk factors for the occurrence of epistaxis: prospective study, Auris Nasus Larynx, 45, 471, 10.1016\u002Fj.anl.2017.07.021\nMasoudian, 2018, ScienceDirect Socioeconomic status and anterior epistaxis in the adult population, World J. Otorhinolaryngol. Head Neck Surg., 4, 263, 10.1016\u002Fj.wjorl.2017.07.001\nVillajos, 2019, Gastroenterología y Hepatología Epistaxis in the cirrhotic patient: a complication to be considered, Rev. Colomb. Gastroenterol., 42, 11\nReis, 2018, Epidemiology of epistaxis in the emergency department of a southern European tertiary care hospital, Acta Otorrinolaringol, 69, 331, 10.1016\u002Fj.otorri.2017.11.002\nYaneza, 2018, J. Head Neck Spine Surg, 36, 543\nShah, 2018, Techniques in septoplasty traditional versus endoscopic approaches, Otolaryngol. Clin. N. Am., 51, 909, 10.1016\u002Fj.otc.2018.05.007\nYang, 2018, Epistaxis health disparities in the United States pediatric population, Int. J. Pediatr. Otorhinolaryngol. Extra, 114, 20, 10.1016\u002Fj.ijporl.2018.08.025\nSapmaz, 2018, A new classification for septal perforation and effects of treatment methods on the quality of life, Braz. J. Otorhinolaryngol., 1\nZhang, 2019, Recent advances in musculoskeletal local drug delivery, Acta Biomater., 19, 135, 10.1016\u002Fj.actbio.2019.01.043\nAlenezi, 2019, Materials Science & Engineering C Development of a photon induced drug-delivery implant coating, Mater. Sci. Eng. C Mater. Biol. Appl., 98, 619, 10.1016\u002Fj.msec.2019.01.015\nIbaraki, 2019, Journal of Drug Delivery Science and Technology Effects of surface charge and flexibility of liposomes on dermal drug delivery, J. Drug Deliv. Sci. Technol., 50, 155, 10.1016\u002Fj.jddst.2019.01.028\nHuang, 2019, Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy, Acta Biomater., 85, 1, 10.1016\u002Fj.actbio.2018.12.028\nTorres, 2019, In vitro evaluation of Pseudomonas aeruginosa chronic lung infection models: are agar and calcium-alginate beads interchangeable?, Eur. J. Pharm. Biopharm., 143, 35, 10.1016\u002Fj.ejpb.2019.08.006\nYin, 2018, A pH-responsive composite hydrogel beads based on agar and alginate for oral drug delivery, J. Drug Deliv. Sci. Technol., 43, 12, 10.1016\u002Fj.jddst.2017.09.009\nOzkan, 2019, A review of microencapsulation methods for food antioxidants: principles, advantages, drawbacks, and applications, Food Chem., 272, 494, 10.1016\u002Fj.foodchem.2018.07.205\nZahmatkesh, 2019, Synthesis of ZnO\u002FIn 2O3 composite nanofibers by co-electrospinning: a comprehensive parametric investigating the process, Ceram. Int., 45, 2530, 10.1016\u002Fj.ceramint.2018.10.184\nCoimbra, 2019, Preparation of gentamicin sulfate eluting fiber mats by emulsion and by suspension electrospinning, Mater. Sci. Eng. C, 94, 86, 10.1016\u002Fj.msec.2018.09.019\nYusof, 2018, Electrospinning of carboxymethyl starch\u002Fpoly (L ‐ lactide acid) composite nanofiber, Polym. Adv. Technol., 29, 1843, 10.1002\u002Fpat.4292\nAydogdu, 2019, Nanostructured poly (lactic acid)\u002Fsoy protein\u002FHPMC films by electrospinning for potential applications in the food industry, Eur. Polym. J., 112, 477, 10.1016\u002Fj.eurpolymj.2019.01.006\nGutiérrez-sánchez, 2019, RGD-functionalization of PLA\u002Fstarch scaffolds obtained by electrospinning and evaluated in vitro for potential bone regeneration, Mater. Sci. Eng. C, 96, 798, 10.1016\u002Fj.msec.2018.12.003\nZheng, 2019, Effects of sodium carboxymethyl cellulose on rheological properties and gelation behaviors of sodium alginate induced by calcium ions, Adv. J. Food Sci. Technol., 103, 131\nMelo, 2019, Preparation, and characterization of polypyrrole\u002Forganophilic montmorillonite nanofibers obtained by electrospinning, J. Mol. Liq., 275, 452, 10.1016\u002Fj.molliq.2018.11.084\nKostakova, 2012, Electrospinning and electrospraying of polymer solutions with spherical fullerenes, NANOCON, 10, 23\nLi, 2004, Electrospinning of nanofibers: reinventing the wheel?, Adv. Mater., 14, 1151, 10.1002\u002Fadma.200400719\nGu, 2013, Polylactic acid composites incorporating casein functionalized cellulose nanowhiskers, J. Biol. Eng., 7, 31, 10.1186\u002F1754-1611-7-31\nHomer, 1999, Nasal pH measurement: a reliable and repeatable parameter, Clin. Otolaryngol., 24, 67, 10.1046\u002Fj.1365-2273.1999.00223.x\nLaf, 2018, Nasal adhesive patches - approach for topical application for the dry nasal syndrome, Int. J. Biol. Macromol., 111, 493, 10.1016\u002Fj.ijbiomac.2018.01.043\nWashington, 2000, Determination of baseline human nasal pH and the effect of intranasally administered buffers, Int. J. Pharm., 198, 139, 10.1016\u002FS0378-5173(99)00442-1\nChien, 2010, Survival prediction of initial blood pH for nontraumatic out-of-hospital cardiac arrest patients in the emergency department, Int. J. Gerontol., 4, 171, 10.1016\u002Fj.ijge.2010.11.002\nSmitha, 2016, Use of agar biopolymer to improve the shear strength behavior of Sabarmati sand, Int. J. Geotech. Eng., 10, 387, 10.1080\u002F19386362.2016.1152674",{"EN":1031},"Development of drug reservoirs based on nanofibers and capsules for epistaxis treatment",{"VOID":1033},"10.1016\u002Fj.jddst.2019.101398","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1773224719313619",[1036,1051,1063,1078,1093],{"id":1037,"sortIndex":245,"researcher":18,"roles":1038,"affiliations":1039,"properties":1048},"5c4b9563-06eb-4bb1-b505-a7b16985ee49",[117],[1040],{"id":18,"sortIndex":19,"affiliation":1041,"properties":18},{"id":1042,"createTime":1043,"updateTime":1043,"relativeEntities":1044,"slug":18,"properties":1045,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"c7895690-3351-4574-973a-fba76202f561","2023-12-25T21:06:08.146+00:00",[],{"title":1046},{"VI":1047},"Federal University of Santa Catarina, Department of Engineering, Blumenau, Zip Code 89036-002, Brazil",{"title":1049},{"VI":1050},"Ana Paula S. Immich",{"id":1052,"sortIndex":19,"researcher":18,"roles":1053,"affiliations":1054,"properties":1060},"7515a68a-3fd7-4af5-83c5-df0177deac6f",[117],[1055],{"id":18,"sortIndex":19,"affiliation":1056,"properties":18},{"id":1042,"createTime":1043,"updateTime":1043,"relativeEntities":1057,"slug":18,"properties":1058,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":1059},{"VI":1047},{"title":1061},{"VI":1062},"Gabriela Maestri",{"id":1064,"sortIndex":214,"researcher":18,"roles":1065,"affiliations":1066,"properties":1075},"0f649ee1-897e-4448-9442-80dc138257e9",[117],[1067],{"id":18,"sortIndex":19,"affiliation":1068,"properties":18},{"id":1069,"createTime":1070,"updateTime":1070,"relativeEntities":1071,"slug":18,"properties":1072,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"7ca1027b-ed3d-40ee-bea9-7247056c4ea5","2023-12-25T21:06:08.189+00:00",[],{"title":1073},{"VI":1074},"Federal University of Santa Catarina, Department of Food and Chemistry Engineering, Florianópolis, Brazil",{"title":1076},{"VI":1077},"Antônio Augusto U. de Souza",{"id":1079,"sortIndex":115,"researcher":18,"roles":1080,"affiliations":1081,"properties":1090},"982266b2-e0c4-42ea-8ad4-e83f6ba59648",[117],[1082],{"id":18,"sortIndex":19,"affiliation":1083,"properties":18},{"id":1084,"createTime":1085,"updateTime":1085,"relativeEntities":1086,"slug":18,"properties":1087,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"89afe539-01e9-4dcd-8701-62c22b52758f","2023-12-07T00:11:51.199+00:00",[],{"title":1088},{"VI":1089},"Hospital Infantil Joana de Gusmão, Florianópolis, Brazil",{"title":1091},{"VI":1092},"Rafael L. Boemo",{"id":1094,"sortIndex":154,"researcher":18,"roles":1095,"affiliations":1096,"properties":1102},"b9b81fec-3bb3-468d-bed3-e12ec2456fb4",[117],[1097],{"id":18,"sortIndex":19,"affiliation":1098,"properties":18},{"id":1042,"createTime":1043,"updateTime":1043,"relativeEntities":1099,"slug":18,"properties":1100,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":1101},{"VI":1047},{"title":1103},{"VI":1104},"Liliana do Amaral Soares",{"url":1034,"publisher":1106,"properties":1128},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1107,"slug":10,"properties":1108,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":1111,"manageAffiliations":1112,"indexDatabases":1113,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":1109,"title":1110},{"VOID":13},{"EN":15},[],[],[1114,1121],{"id":73,"indexDatabase":1115,"url":86,"indexYears":87,"academicFieldIds":1120,"indexDatabaseRanking":90},{"id":75,"createTime":76,"updateTime":77,"relativeEntities":1116,"label":1117,"description":1118,"key":83,"publicationTags":1119,"standard":18},[],{"EN":80,"VI":80},{"EN":80,"VI":82},[85],[89],{"id":54,"indexDatabase":1122,"url":69,"indexYears":18,"academicFieldIds":1127,"indexDatabaseRanking":18},{"id":56,"createTime":57,"updateTime":58,"relativeEntities":1123,"label":1124,"description":1125,"key":65,"publicationTags":1126,"standard":18},[],{"EN":61,"VI":61},{"VI":63,"EN":64},[67,68],[71],{"volume":1129,"pages":1131},{"VOID":1130},"55",{"VOID":1132},"101398","2020-02-01",2020,{"id":1136,"createTime":1137,"updateTime":1137,"relativeEntities":1138,"slug":18,"properties":1139,"entityType":108,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"primaryUrl":1146,"fullTextUrl":18,"authors":1147,"publicationType":165,"publisherRelationship":1297,"citationCount":18,"citationInfo":18,"publishDate":1325,"publishYear":1326,"citationAnalyzeStatus":17,"lastCitationAnalyze":18,"indexDatabases":18,"openAccess":18,"references":18,"isForceReanalyzing":196},"1187b201-8930-4c7a-bdd7-22d4414600ef","2024-01-05T23:52:35.300+00:00",[],{"references":1140,"title":1142,"doi":1144},{"VOID":1141},"Mao, 2022, Integrative oncology: addressing the global challenges of cancer prevention and treatment, CA Cancer J. Clin., 72, 144, 10.3322\u002Fcaac.21706\nCorrie, 2008, Cytotoxic chemotherapy: clinical aspects, Medicine, 36, 24, 10.1016\u002Fj.mpmed.2007.10.012\nTacar, 2012, Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems, J. Pharm. Pharmacol., 65, 157, 10.1111\u002Fj.2042-7158.2012.01567.x\nCummings, 1993, DNA topoisomerase-1 and topoisomerase-2 as targets for rational design of new anticancer drugs, Ann. Oncol., 4, 533, 10.1093\u002Foxfordjournals.annonc.a058584\nEvison, 2016, Mitoxantrone, more than just another topoisomerase II Poison, Med. Res. Rev., 36, 248, 10.1002\u002Fmed.21364\nDantchev, 1984, Comparative microscopic study of cardiotoxicity and skin toxicity of anthracycline analogs, Biomed. Pharmacother., 38, 322\nBontenbal, 1992, Weekly low-dose mitoxantrone plus doxorubicin as second-line chemotherapy for advanced breast cancer, Breast Cancer Res. Treat., 21, 133, 10.1007\u002FBF01836959\nStewart, 1987, Combined mitoxantrone plus doxorubicin in the treatment of breast cancer, Am. J. Clin. Oncol., 10, 335, 10.1097\u002F00000421-198708000-00016\nKurbacher, 1996, Heterogeneity of in vitro chemosensitivity in perioperative breast cancer cells to mitoxantrone versus doxorubicin evaluated by a microplate ATP bioluminescence assay, Breast Cancer Res. Treat., 41, 161, 10.1007\u002FBF01807161\nDamiani, 2016, Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone, Arch. Toxicol., 90, 2063, 10.1007\u002Fs00204-016-1759-y\nBarenholz, 2012, Doxil — the first FDA-approved nano-drug: lessons learned, J. Contr. Release, 160, 117, 10.1016\u002Fj.jconrel.2012.03.020\nYuan, 2021, Conjugation with nanodiamonds via hydrazone bond fundamentally alters intracellular distribution and activity of doxorubicin, Int. J. Pharm. (Amst.), 606\nGao, 2019, Nanodiamond‐based theranostic platform for drug delivery and bioimaging, Small, 15, 10.1002\u002Fsmll.201902238\nGarifo, 2021, Nanodiamonds as nanomaterial for biomedical field, Front. Mater. Sci., 15, 334, 10.1007\u002Fs11706-021-0567-3\nXu, 2021, Synergy of nanodiamond–doxorubicin conjugates and PD-L1 blockade effectively turns tumor-associated macrophages against tumor cells, J. Nanobiotechnol., 19, 268, 10.1186\u002Fs12951-021-01017-w\nTurcheniuk, 2017, Biomedical applications of nanodiamond, Nanotechnology, 28, 10.1088\u002F1361-6528\u002Faa6ae4\nWhitlow, 2017, Multifunctional nanodiamonds in regenerative medicine: recent advances and future directions, J. Contr. Release, 261, 62, 10.1016\u002Fj.jconrel.2017.05.033\nEstrella, 2013, Acidity generated by the tumor microenvironment drives local invasion, Cancer Res., 73, 1524, 10.1158\u002F0008-5472.CAN-12-2796\nAnderson, 2020, The tumor microenvironment, Curr. Biol., 30, R921, 10.1016\u002Fj.cub.2020.06.081\nLi, 2016, Smart pH-responsive and high doxorubicin loading nanodiamond for in vivo selective targeting, imaging, and enhancement of anticancer therapy, J. Mater. Chem. B, 4, 5046, 10.1039\u002FC6TB00266H\nWu, 2023, A nanodiamond chemotherapeutic folate receptor-targeting prodrug with triggerable drug release, Int. J. Pharm. (Amst.), 630\nWang, 2018, Stimuli-responsive nanodiamond-based biosensor for enhanced metastatic tumor site detection, SLAS Technol, 23, 44, 10.1177\u002F2472630317735497\nDeng, 2017, Nanoparticle interactions with co-existing contaminants: joint toxicity, bioaccumulation and risk, Nanotoxicology, 11, 1, 10.1080\u002F17435390.2017.1343404\nMiller, 2017, Inhaled nanoparticles accumulate at sites of vascular disease, ACS Nano, 11, 4542, 10.1021\u002Facsnano.6b08551\nMiller, 2017, Correction to“inhaled nanoparticles accumulate at sites of vascular disease”, ACS Nano, 11, 10623, 10.1021\u002Facsnano.7b06327\nWang, 2021, Safety evaluation of nanodiamond-doxorubicin complexes in a Naïve Beagle canine model using hematologic, histological, and urine analysis, Nano Res., 1\nToh, 2014, Nanodiamond-mitoxantrone complexes enhance drug retention in chemoresistant breast cancer cells, Mol. Pharm., 11, 2683, 10.1021\u002Fmp5001108\nLi, 2019, Ultrasound-enhanced delivery of doxorubicin-loaded nanodiamonds from pullulan-all-trans-retinal nanoparticles for effective cancer therapy, ACS Appl. Mater. Interfaces, 11, 20341, 10.1021\u002Facsami.9b03559\nBukowski, 2020, Mechanisms of multidrug resistance in cancer chemotherapy, Int. J. Mol. Sci., 21, 3233, 10.3390\u002Fijms21093233\nWang, 2022, Recent advances in anti-multidrug resistance for nano-drug delivery system, Drug Deliv., 29, 1684, 10.1080\u002F10717544.2022.2079771\nZhu, 2017, Nanodiamond mediated co-delivery of doxorubicin and malaridine to maximize synergistic anti-tumor effects on multi-drug resistant MCF-7\u002FADR cells, J. Mater. Chem. B, 5, 3531, 10.1039\u002FC7TB00449D\nLi, 2018, Ultrasound-enhanced delivery of doxorubicin\u002Fall-trans retinoic acid-loaded nanodiamonds into tumors, Nanomedicine, 13, 981, 10.2217\u002Fnnm-2017-0375\nChou, 2010, Drug combination studies and their synergy quantification using the Chou-Talalay method, Cancer Res., 70, 440, 10.1158\u002F0008-5472.CAN-09-1947\nDu, 2020, A tumor-targeted, intracellular activatable and theranostic nanodiamond drug platform for strongly enhanced in vivo antitumor therapy, J. Mater. Chem. B, 8, 1660, 10.1039\u002FC9TB02259G\nRidha, 2021, A promising dual-drug targeted delivery system in cancer therapy: nanocomplexes of folate-apoferritin-conjugated cationic solid lipid nanoparticles, Pharmaceut. Dev. Technol., 26, 673, 10.1080\u002F10837450.2021.1920037\nXiao, 2011, The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles, Biomaterials, 32, 3435, 10.1016\u002Fj.biomaterials.2011.01.021\nCagel, 2017, Doxorubicin: nanotechnological overviews from bench to bedside, Drug Discov. Today, 22, 270, 10.1016\u002Fj.drudis.2016.11.005\nAshton, 2015, Drug combination studies and their synergy quantification using the Chou-Talalay method, Cancer Res., 75, 2400, 10.1158\u002F0008-5472.CAN-14-3763\nShi, 2015, Co-delivery of docetaxel and chloroquine via PEO–PPO–PCL\u002FTPGS micelles for overcoming multidrug resistance, Int. J. Pharm. (Amst.), 495, 932, 10.1016\u002Fj.ijpharm.2015.10.009\nVandergraaf, 1994, Effects of amiodarone, cyclosporine-a, and psc-833 on the cytotoxicity of mitoxantrone, doxorubicin, and vivcristine in non-p-glycoprotein human small-cell lung -cancer cell lines, Cancer Res., 54, 5368\nDeniaud, 2008, Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis, Oncogene, 27, 285, 10.1038\u002Fsj.onc.1210638\nHaeberlein, 2004, Mitochondrial function in apoptotic neuronal cell death, Neurochem. Res., 29, 521, 10.1023\u002FB:NERE.0000014823.74782.b7\nDong, 2015, Folate-conjugated nanodiamond for tumor-targeted drug delivery, RSC Adv., 5, 82711, 10.1039\u002FC5RA12383F\nWang, 2013, PEGylated nanodiamond for chemotherapeutic drug delivery, Diam. Relat. Mater., 36, 26, 10.1016\u002Fj.diamond.2013.04.002\nRashid, 2001, Synergistic growth inhibition of prostate cancer cells by 1 alpha,25 Dihydroxyvitamin D-3 and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A, Oncogene, 20, 1860, 10.1038\u002Fsj.onc.1204269\nGuicciardi, 2004, Lysosomes in cell death, Oncogene, 23, 2881, 10.1038\u002Fsj.onc.1207512\nMaeda, 2010, Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects, Bioconjugate Chem., 21, 797, 10.1021\u002Fbc100070g\nMaeda, 2013, The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo, Adv. Drug Deliv. Rev., 65, 71, 10.1016\u002Fj.addr.2012.10.002\nNichols, 2014, EPR: evidence and fallacy, J. Contr. Release, 190, 451, 10.1016\u002Fj.jconrel.2014.03.057\nChen, 2015, Theranostic applications of carbon nanomaterials in cancer: focus on imaging and cargo delivery, J. Contr. Release, 210, 230, 10.1016\u002Fj.jconrel.2015.04.021\nGuissi, 2017, Mitoxantrone- and folate-TPGS2k conjugate hybrid micellar aggregates to circumvent toxicity and enhance efficiency for breast cancer therapy, Mol. Pharm., 14, 1082, 10.1021\u002Facs.molpharmaceut.6b01009\nWei, 2019, OFF-ON nanodiamond drug platform for targeted cancer imaging and therapy, J. Mater. Chem. B, 7, 3390, 10.1039\u002FC9TB00447E",{"EN":1143},"Enhanced in vivo antitumor efficacy through the nanodiamond mediated co-delivery of drugs",{"VOID":1145},"10.1016\u002Fj.jddst.2023.104984","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1773224723008365",[1148,1164,1181,1196,1214,1226,1238,1250,1265,1277],{"id":1149,"sortIndex":1150,"researcher":18,"roles":1151,"affiliations":1152,"properties":1161},"0c89b771-d782-463d-9323-83d6d15303f2",7,[117],[1153],{"id":18,"sortIndex":19,"affiliation":1154,"properties":18},{"id":1155,"createTime":1156,"updateTime":1156,"relativeEntities":1157,"slug":18,"properties":1158,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"b4629e28-25c7-4890-ba55-394ec170a6f8","2024-01-05T23:52:35.393+00:00",[],{"title":1159},{"VI":1160},"Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Institute of Biotechnology, Shanxi University, Taiyuan, 030006, China",{"title":1162},{"VI":1163},"Yuejun Fu",{"id":1165,"sortIndex":115,"researcher":18,"roles":1166,"affiliations":1167,"properties":1178},"d0b6bf76-fb73-47de-9146-a3308cb897d3",[117],[1168],{"id":18,"sortIndex":19,"affiliation":1169,"properties":18},{"id":1170,"createTime":1171,"updateTime":1172,"relativeEntities":1173,"slug":1174,"properties":1175,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"db877c85-0a47-44f9-821d-8dee5d81a533","2023-12-05T09:19:47.079+00:00","2024-11-29T12:30:26.054+00:00",[],"School-of-Chemistry-and-Chemical-Engineering-Shanxi-University-Taiyuan-030006-PR-China",{"title":1176},{"VI":1177},"School of Chemistry and Chemical Engineering, Shanxi University, Taiyuan, 030006, PR China",{"title":1179},{"VI":1180},"Wenjing Zhao",{"id":1182,"sortIndex":214,"researcher":18,"roles":1183,"affiliations":1184,"properties":1193},"4e9ed2de-63ae-455c-80ef-d8da4d3acfb6",[117],[1185],{"id":18,"sortIndex":19,"affiliation":1186,"properties":18},{"id":1187,"createTime":1188,"updateTime":1188,"relativeEntities":1189,"slug":18,"properties":1190,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"18b9dffe-85fd-4602-bd62-13fbccfbf5b9","2024-01-05T23:52:35.345+00:00",[],{"title":1191},{"VI":1192},"Taiyuan Central Hospital, Taiyuan, 030009, PR China",{"title":1194},{"VI":1195},"Dongmei Zhang",{"id":1197,"sortIndex":1198,"researcher":18,"roles":1199,"affiliations":1200,"properties":1211},"5d486444-9bfb-43fb-8c98-fc21606c9bdd",8,[117],[1201],{"id":18,"sortIndex":19,"affiliation":1202,"properties":18},{"id":1203,"createTime":1204,"updateTime":1205,"relativeEntities":1206,"slug":1207,"properties":1208,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"02a64ac0-e809-458d-88ab-702bf96f9ac0","2024-01-04T11:41:52.798+00:00","2025-06-11T16:02:43.456+00:00",[],"Department-of-Chemistry-and-Biochemistry-University-of-Windsor-Windsor-ON-N9B-3P4-Canada",{"title":1209},{"VI":1210},"Department of Chemistry and Biochemistry, University of Windsor, Windsor, ON N9B 3P4, Canada",{"title":1212},{"VI":1213},"John F. Trant",{"id":1215,"sortIndex":154,"researcher":18,"roles":1216,"affiliations":1217,"properties":1223},"dad0a92d-415d-4bd3-9b56-fecb22eabcba",[117],[1218],{"id":18,"sortIndex":19,"affiliation":1219,"properties":18},{"id":1170,"createTime":1171,"updateTime":1172,"relativeEntities":1220,"slug":1174,"properties":1221,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":1222},{"VI":1177},{"title":1224},{"VI":1225},"Jiangtao Wu",{"id":1227,"sortIndex":511,"researcher":18,"roles":1228,"affiliations":1229,"properties":1235},"e98ecaee-3b64-48bc-bf65-6fc6e61755b8",[117],[1230],{"id":18,"sortIndex":19,"affiliation":1231,"properties":18},{"id":1170,"createTime":1171,"updateTime":1172,"relativeEntities":1232,"slug":1174,"properties":1233,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":1234},{"VI":1177},{"title":1236},{"VI":1237},"Zeyu Yan",{"id":1239,"sortIndex":245,"researcher":18,"roles":1240,"affiliations":1241,"properties":1247},"5023d439-9b89-481f-bab4-67536fffc5b5",[117],[1242],{"id":18,"sortIndex":19,"affiliation":1243,"properties":18},{"id":1170,"createTime":1171,"updateTime":1172,"relativeEntities":1244,"slug":1174,"properties":1245,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":1246},{"VI":1177},{"title":1248},{"VI":1249},"Longguang Liu",{"id":1251,"sortIndex":40,"researcher":18,"roles":1252,"affiliations":1253,"properties":1262},"99369211-e9dd-4789-bb08-6bbc211565ea",[117],[1254],{"id":18,"sortIndex":19,"affiliation":1255,"properties":18},{"id":1256,"createTime":1257,"updateTime":1257,"relativeEntities":1258,"slug":18,"properties":1259,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},"10880d3d-cd9a-47e3-808f-c3b2a533a8ec","2024-01-11T09:32:41.593+00:00",[],{"title":1260},{"VI":1261},"Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Institute of Molecular Science, Shanxi University, Taiyuan 030006, PR China",{"title":1263},{"VI":1264},"Hui Qiao",{"id":1266,"sortIndex":19,"researcher":18,"roles":1267,"affiliations":1268,"properties":1274},"72ce2e6b-3e47-4835-b568-7254847839eb",[117],[1269],{"id":18,"sortIndex":19,"affiliation":1270,"properties":18},{"id":1256,"createTime":1257,"updateTime":1257,"relativeEntities":1271,"slug":18,"properties":1272,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":1273},{"VI":1261},{"title":1275},{"VI":1276},"Jicheng Cui",{"id":1278,"sortIndex":1279,"researcher":18,"roles":1280,"affiliations":1281,"properties":1294},"99ae9a16-fce3-49b0-b549-3180c6bde12a",9,[117],[1282,1289],{"id":1283,"sortIndex":115,"affiliation":1284,"properties":1288},"e8357ef7-f02f-4ea9-9154-decb8b3e02c0",{"id":1256,"createTime":1257,"updateTime":1257,"relativeEntities":1285,"slug":18,"properties":1286,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":1287},{"VI":1261},{},{"id":18,"sortIndex":19,"affiliation":1290,"properties":18},{"id":1170,"createTime":1171,"updateTime":1172,"relativeEntities":1291,"slug":1174,"properties":1292,"entityType":39,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19},[],{"title":1293},{"VI":1177},{"title":1295},{"VI":1296},"Yingqi Li",{"url":1146,"publisher":1298,"properties":1320},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1299,"slug":10,"properties":1300,"entityType":16,"verifyStatus":17,"verifyTime":18,"verifyNote":18,"syncStatus":17,"languages":18,"translateLanguages":18,"viewCount":19,"subjectFields":1303,"manageAffiliations":1304,"indexDatabases":1305,"url":18,"thumbnailPath":18,"statistic":18,"gsStatistic":18,"type":18,"analyzePriority":18},[],{"issn":1301,"title":1302},{"VOID":13},{"EN":15},[],[],[1306,1313],{"id":73,"indexDatabase":1307,"url":86,"indexYears":87,"academicFieldIds":1312,"indexDatabaseRanking":90},{"id":75,"createTime":76,"updateTime":77,"relativeEntities":1308,"label":1309,"description":1310,"key":83,"publicationTags":1311,"standard":18},[],{"EN":80,"VI":80},{"EN":80,"VI":82},[85],[89],{"id":54,"indexDatabase":1314,"url":69,"indexYears":18,"academicFieldIds":1319,"indexDatabaseRanking":18},{"id":56,"createTime":57,"updateTime":58,"relativeEntities":1315,"label":1316,"description":1317,"key":65,"publicationTags":1318,"standard":18},[],{"EN":61,"VI":61},{"VI":63,"EN":64},[67,68],[71],{"volume":1321,"pages":1323},{"VOID":1322},"88",{"VOID":1324},"104984","2023-10-01",2023]